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Abstract
This thesis presents mathematical models describing the mechanical behavior of the human
aortic heart valve over a range of length and time scales. In the human heart, the valves perform
the vital function of controlling the direction of blood flow. Each valve is an intricate mechanical
structure, with distinct features and functions at multiple scales. This effort first develops a
framework of reference configurations that enables communication between simulations of the
different length scales. Three simulations are created within that framework. At the cell scale, the
interaction between a single valvular interstitial cell and its surrounding matrix is described. At
the tissue scale, a model is created for the valve cusp tissue mechanical behavior, including the
multilayered, nonuniform geometry and nonlinear, anisotropic material properties. At the organ
scale, a dynamic, three-dimensional model with fluid-structure interaction predicts the motion of
the valve, blood, and surrounding tissue. Each simulation is verified against a number of
experimental measures. These three simulations together constitute a model for the dynamic,
three-dimensional, multiscale mechanical behavior of the healthy human aortic heart valve
throughout the cardiac cycle.
The model is employed to perform multiscale investigation into the mechanisms of the disease
calcific aortic stenosis in three ways. First, the model of the healthy valve is extended to describe
disease progression on the decade time scale. Calcification is introduced at the tissue level and
the effects on valve function are monitored at the organ level. Second, the role of mechanical
deformations in the disease process is examined by comparing multiscale deformations between
the normal valve case and a known disease-prone case. Finally, a combined computational and
experimental study investigates the role of fluid shear in calcific disease. Shears computed in the
organ-scale simulation are applied to endothelial cells in vitro. The cells express disease-related
genes in a manner consistent with the region-specific nature of calcific disease, providing
evidence for a role of shear in the disease process. The multiscale model presented in this thesis
has further utility in investigating function, disease, and therapy of the human aortic valve.
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Chapter 1. Introduction to the Mathematical Modeling of
Human Heart Valves
Multiscale Mechanics of Human Heart Valves
The human heart is a pump system consisting of four chambers and four valves. As the chambers
contract to eject blood, the valves open and close in sequence to control the direction of flow.
The locations of these valves and flow paths through the heart are illustrated in Figure 1.1.
nght heart
0 ainrr vcrm Cava
0 rish atrium
n tri-advahv
left hear
198Figure 1.1. Valves of the human heart and flow directions .
Mechanical behavior of the valves can be examined at the molecular, cellular, tissue, and whole
organ length scales (Figure 1.2). Here, we briefly describe the valve mechanical behavior at each
scale.
Schotenl997
iFastenrathl995)
Figure 1.2. Representation of the multiscale nature of heart valve mechanics: organ, tissue, cell,
and molecule scale features
Organ Scale
Each of the heart valves consists of a number of tissue flaps. Generally the tissue flaps of the
aortic and pulmonary valves are referred to as the 'cusps' and those in the mitral and tricuspid
valves are referred to as 'leaflets'. In this thesis, we will use the term leaflet when discussing the
natural valves together, bioprosthetic valves, or mechanical valves, and use the term cusps only
when specifically addressing the natural aortic or pulmonary valve. The aortic, pulmonary, and
tricuspid valve each normally have three leaflets and the mitral valve has two. Leaflets
themselves are passive, opening and closing when forced by the blood. Healthy heart valves
open widely, providing an unobstructed flow path, and seal closed. Photos of an aortic valve
(AV) in its open and closed position are shown in Figure 1.3. The valves move quickly between
their open and closed positions and require little force to do so.
Figure 1.3. Valve open and closed' 21
As the heart grows over the human lifetime, the valves must also grow proportionally to adapt to
the increased pressure and flow configurations. Moreover, the valves change shape as the heart
moves and contracts during the cardiac cycle. Additionally, the mitral and tricuspid valves
include chordae tendinae, chord-like structures that connect the cusps to muscles on the ventricle
wall and that help the valves maintain their closed shape and open rapidly.
Tissue Scale
Valve leaflet tissues have a number of unique features as illustrated in Figure 1.4, a micrograph
cross-section of AV leaflet. These thin tissues (0.2-2.0mm)s8 are composed of three layers. The
21
1
ventricularis is below the inflow surface. This is the thinnest layer, and consists mostly of
collagen with some elastin. Below the outflow surface, the thicker fibrosa is composed of aligned
collagen . The fibrosa is crimped when the tissue is unstressed, and these crimps flatten when
the tissue is tensed due to pressurization of the valve158. Between the two fibrous layers exists the
gel-like spongiosa'6 5
Figure 1.4. Micrograph cross-section of AV leaflet showing tissue layers and cells"'•
Cell Scale
Two types of cells are found within the valve leaflets, both shown in Figure 1.4. The valvular
interstitial cells (ICs) are distributed throughout the extracellular matrix (ECM), and the valvular
endothelial cells (ECs) coat all of the blood-facing surfaces. ICs are responsible for maintaining
the extracellular matrix and modulating disease pathology1 7. In the valve, ICs display a number
of different phenotypes at different locations, and share some characteristics with fibroblasts and
some with skeletal, cardiac, and smooth muscle cells 37 122, 152, 177. ICs are known to remodel over
the human lifetime 143, respond to physical deformations83, and engage in signaling with other ICs
22
and the ECM37. Similarly, the ECs have spatially varying phenotypes' 67, respond to mechanical
stimuli 189, regulate valve pathologies 26, and engage in signaling26.
Molecular Scale
Heart valve leaflets are composed of fibrous matrices, in which a sponge-like matrix of elastin
surrounds bundles of collagen fiber1 77. The fibers are aligned in the plane of the leaflet and
organized into three layers, the fibrosa, spongiosa, and ventricularis. The collagen and elastin
exist in a hydrated gel-like ground substance, composed of proteoglycans and
glycosaminoglycans78. Collagen and elastin are kinked fibers that can straighten under small
loads, allowing large extension of the tissue at low stresses. Micrographs of the matrix structure
are shown in Figure 1.5.
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In the heart valves, distinct mechanical behaviors can be observed at the molecule, cell, tissue,
and organ length scales. Additionally, there is mechanical communication between the scales,
where behavior at one scale impacts behavior at another scale. This communication can proceed
either from a smaller to a larger scale or the opposite. The main mechanical communication from
the smaller scale up determines the overall function of the valve: the extensibilities and
geometric organization of the fibrous molecules determines the tissue stiffness and anisotropy' 3'
14 which, along with the tissue-scale geometry, determines the organ-scale motion of the
cusps' 93 . There is active communication from the cell scale to the tissue scale, where contraction
of the ICs significantly affects tissue stiffness' 23. Mechanical communication from the larger
scales downwards affects active biochemical processes. In the fluid, organ-scale fluid motion
applies shears to the ECs. In the solid, organ-scale motion deforms the tissue, which in turn
deforms the ICs. Mechanical signals control gene expression in normal and diseased states of the
ECs26, 189 and ICs11 7, 152, 177
Heart Valve Dysfunction
Healthy heart valves operate efficiently, easily moving between an unobstructed open
configuration and a fully sealed closed configuration. A variety of disorders can prevent a valve
from opening fully (stenosis), keep the valve from sealing closed (regurgitation), or cause other
dysfunction. Here, we briefly review the pathologies of common heart valve disorders and
current courses of treatment.
Disorders
Aortic stenosis (AS) is the most common valve disease, occurring in 2% to 4% of adults over 65
years in age ". In calcific aortic stenosis, calcified nodes, shown in Figure 1.6, develop on the
AV cusps. These nodes make the cusps stiff, preventing the valve from opening fully and thus
obstructing flow 35, 179. AS may be caused either by age-related wear on the valve or by
rheumatic diseases 15. Stenosis of the tricuspid or pulmonary valves is known but rare. Mitral
stenosis (MS) is more common and generally caused by rheumatic fever' 15
Figure 1.6. Photographs of (left) healthy AV and (right) severely calcified valve 70
Regurgitation is observed most commonly in the mitral valve. Mitral regurgitation (MR) may be
caused by a variety of underlying conditions. Valve degeneration, papillary muscle dysfunction,
infective endocarditis, rheumatic disease, and enlargement of the left ventricle can all impair
mitral valve closure"' 5 . Aortic regurgitation (AR) can also occur, with similar causes of either
tissue disease or orifice enlargement 35. Tricuspid and pulmonary valve regurgitation are
generally functional rather than structural, meaning they develop in response to pressure
overload and not due to a mechanical defect of the valve itself" .
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A few valve diseases exist that are neither stenotic nor regurgitant. Mitral valve prolapse (MVP)
refers to a condition where the mitral valve bulges out significantly under pressure. In bicuspid
aortic valve (BAV), occurring congenitally in 1-2% of the population 134' 179, the AV has two
cusps instead of three. MVP115, BAV1 1', and other valve malformations are often precursors to
regurgitation and stenosis.
Treatments
Each valve disorder has a different course of treatment. These therapies fall into three main
categories. First, pharmaceutical drugs may be used to prevent or limit the progression of
disease. No drugs exist to treat most valve diseases, but statins show promise in inhibiting
calcific aortic stenosis 129, 137, 150. A second approach to treating valve disease is to surgically
repair a mechanical defect. A common example is resection of the flailing mitral valve posterior
leaflet, illustrated in Figure 1.7. Surgery is possible in specific cases of stenosis and
regurgitation of any of the valves 195' 196, with new methods continuously being developed28' 44
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Figure 1.7. Illustration of quadrangular resection to correct prolapsing mitral leaflet. Excess tissue
is removed, the remaining leaflet is sutured, and a ring is attached to the annulus to provide
structural support196
In the vast majority of cases, the only current approach to correcting a failing valve is to replace
the entire valve and sometimes also the surrounding tissue. Development of valve replacement
methods has proceeded rapidly over the past four decades, and represents a great achievement in
the field of biomedical engineering. As illustrated in Figure 1.8, valve replacement enormously
increases patient survival.
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Figure 1.8. Survival curves for operated and unoperated patients with aortic stenosis' 66
A prototype of one of the first mechanical valves is shown in Figure 1.9.A., a ball-in-cage type.
Currently, mechanical valves and bioprosthetic valves are both used for replacement of all
valves. Modem mechanical valves are based on a tilting disc (Figure 1.9.B.), and modem
bioprosthetic valves are constructed from glutaraldehyde-fixed porcine tissue. Current research is
directed towards reducing thrombogenicity of mechanical valves5 3, increasing durability of
bioprosthetic valves" 7 , and development of tissue-engineered solutions 121. Much research in the
simulation of heart valve mechanics has focused on simulating the mechanical and bioprosthetic
valves, perhaps more so than the natural valves.
A)
B) V
Figure 1.9. Various prosthetic heart valves. A) Prototype of the Starr Edwards ball-in-cage
valve' 69 B) Modem tilting disc prosthesis ©Medtronic 2008 C) Modem bioprosthetic valve
CMedtronic 2008
Enabling Experimental Tools
Experimental investigation of mechanics at each length scale relies on methods from a disparate
range of disciplines. We highlight some of the common and emerging technologies that have
been applied specifically to heart valves.
Organ Scale
In the clinical setting, the health of a patient's valve may be assessed in a number of ways. The
classic method of listening to heart sounds can detect and, along with other physical
examination, diagnose abnormalities21' 15. Cardiac catheterization can be used to examine the
valve for calcification or other defects 21 . Valve disease is most commonly evaluated by chest
echocardiograph 87, 136, which allows measurements of fluid motion and valve geometry that can
be compared to various indices for valve disease4' 5, 17, 75, 183. An example of typical images used
for evaluation of aortic stenosis is shown in Figure 1.10. Researchers have recently demonstrated
MR197 and CT 2' 67, 68 methods able to resolve valve motion, holding promise that modem
imaging methods may be applied to clinical examination of valves.
A) B)
Figure 1.10. Standard evalulation of aortic stenosis severity by chest imaging: A) visual
measurement of valve orifice diameter and B) pulsed Doppler measurement of fluid velocity' 36
A number of laboratory methods available to examine organ-scale valve motion cannot be used
on patients. A pulse chamber can be used to subject physiological flows to valves, where valve
deformation can be monitored by optical methods66' 73, 88, 96, 173 and fluid motion can be measured
by particle velocimetry 31. Valve motion has been measured in large-animal models by tracking
sonocrystals attached to the leaflets 179 and fluid velocity profiles have been measured in the
animal models by hot-wire anemometry 6 2.
Tissue Scale
Tissue mechanical properties have historically been measured by Instron-type uniaxial tester40,
126, 151, 163, 180, 185, 186. The Sacks group has pioneered use of optically-measured methods that, in
concert with development of theoretical tools, has enabled rigorous description of multilayer,
anisotropic, nonlinear, tissue properties in both biaxial and bending deformations' 59' 160
31
Standard histology methods give two-dimensional pictures of tissue microstructure, like that in
Figure 1.4. New imaging methods extend this capability to three dimensions. Figure 1.11 shows
the three-dimensional geometry of an AV cusp rendered by high-frequency ultrasound' 09.
Figure 1.11. Image of three-dimensional AV cusp tissue structure, rendered by high-frequency
ultrasound"°9.
Cell Scale
Methods for measuring the mechanical properties of cells have been developed1 16 and recently
applied to ICs 123. Figure 1.12 shows an IC being probed by micropipette aspiration. Pressure is
applied to the cell via the pipette, and cell mechanical properties are deduced from the observed
deformations. Cell deformations in diastole have also been quantified by pressurizing and fixing
a valve, then optically observing the cell nuclei aspect ratios94
Figure 1.12. Micropipette aspiration of a tricuspid valve IC. Pipette pressure increases from left to
right. Scale bar is 5 microns 23.
Molecule Scale
Like the larger scales, the tools molecular mechanics drawn from other fields have been applied
or show promise for application to heart valves. Methods for single-molecule mechanics, such as
laser traps demonstrated on collagen 18 are directly applicable to heart valve matrix components.
Imaging capabilities have reached the molecular level and have recently been applied to
examining heart valve leaflet structure. Figure 1.13 shows an image produced by femtosecond
laser pulse of the three-dimensional network of collagenous and elastic fibers in the heart valve
leaflet164
15 pm
Figure 1.13. Three-dimensional reconstruction of ovine aortic heart valve leaflet by femtosecond
laser pules. Collagenous fibers are shown in blue and elastic fibers in red' 64
Multi-Scale
While many tools are available to investigate the mechanical behavior at each scale, few
experimental approaches have been developed that span multiple scales. Huang et al. measured
the cell-scale deformations in response to pressures applied at the organ scale 94, Merryman et al
measured the tissue mechanical behavior in response to cellular contraction 22, and in this thesis
we will measure the cellular response to organ-scale shear' 89
Enabling Theoretical Tools
The field of mathematical modeling of heart valve mechanics has grown from nonexistent to a
broad discipline in three decades. This expansion is due both to development of mathematical
approach and computational tools to describe relevant mechanical behavior and to the increased
availability of computational power necessary to simulate complex biomechanical dynamics.
Here, we discuss some of the advances in general numerical biomechanics that will be applied to
heart valves in the following sections.
Organ Scale
Using finite-element analysis (FEA) to calculate the motion of heart valves is a challenging
mathematical problem. Leaflets undergo large strains (up to 40%) as well as very large
displacements and rotations. Simulation of these deformations has been enabled by the
development of the nonlinear Updated Lagrange and Total Lagrange approaches to large-
deformation solid mechanics 7. A further difficulty is modeling the interaction between the
leaflets and blood, both of which move dynamically throughout the cardiac cycle. Two primary
methods have been developed and implemented for such large-displacement fluid-structure
interactions (FSI). In the Arbitrary Lagrange-Eulerian (ALE) method, the solid and fluid meshes
are connected, and the fluid mesh is adaptively modified around the moving solid7 . In the
operator-split method, a moving solid mesh can pass through a stationary mesh 84. Increased
computational power has enabled more complete models of heart valve organ-scale behavior.
Where running a solid-only simulation with linear elastic models once required nearly a day on a
supercomputer 76, only five years later a full FSI with nonlinear materials can be performed in a
few hours on a personal computerl 93
Tissue Scale
The two main advancements in mechanical modeling at the tissue scale are the development of
constitutive models for biological tissues and the tools to implement those models in the FEA
setting. Constitutive modeling of tissue behavior requires the theoretical framework provided by
continuum mechanics 72, 89. The initial insight upon which the rest of the field is based was
Fung's demonstration that biological tissues behave in a hyperelastic manner. That is, these
matrices of fiber and water have nonlinear, usually exponential loading curves, but follow the
same curve in loading and unloading 71' 72. Further work has shown that heart valve tissue has
pseudoelastic (different loading and unloading curves)" 19 and viscoelastic behavior 13' 82 in
relevant regimes, but modeling the valve tissues as elastic is a currently accepted practice. With
the assumption of elasticity and the additional assumption that the tissue can be represented as
continuous, the material behavior can be described by an elastic strain energy density function,
W. This function tells the strain energy in terms of the tissue deformation. Once W is defined, the
stresses in the tissue can be calculated by taking the derivative with respect to strain,
aw
r = I- , (Eq. 1.1)
where o is the Cauchy (true) stress tensor and e is the Green strain tensor. Researchers are now
able to construct strain energy functions that can describe the complex behaviors of biological
tissues: anisotropy, nonlinearity, and nonhomogeneity, all with large deformations. For
implementation in FEA software, the function must additionally be numerically well-behaved.
Some reasonably constructed models for biological tissue have been shown to not possess
necessary behavior, namely convexity91
Once an appropriate W has been formulated, it is another matter to implement the model in FEA
software. A great deal of effort has gone into the creation of rigorous methods for modeling
three-dimensional materials in FE. Sussman created the mixed (u/p) formulation commonly used
to model arbitrary incompressible materials with three-dimensional finite elements 175, and others
have implemented anisotropic and biological material models3' 153. Valve leaflets, being quite
thin, are commonly modeled with shell rather than three-dimensional elements 90' 105. For these
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elements a separate and equally significant effort has gone towards creating a theoretical
framework for using shells to model large deformations in general 6' 12, 33, 54, 176, 192 and tools for
handling complex materials models105.
Cell Scale
Two main types of models have been proposed for cell mechanical behavior. Most follow the
continuum assumption and describe the cell as some combination of fluid and solid enveloped by
the cell membrane 116, 127 Other models take a structural approach, treating the cytoskeleton as
the main structural component 116, 127
Molecule Scale
While mechanics at the cell, tissue, and organ scale can usually be described by continuum
mechanics, the continuum assumption does not hold at the molecular level. Molecular dynamics
(MD) simulations must be used to analyze molecule-scale interactions. Like in FE analysis, MD
has progressed rapidly in recent years. We are not aware of MD having been applied to heart
valves. See Sotomayor for a review of the field 168
Multi-Scale
Once simulations are created across a distinct set of length scales, new methods may need to be
created to link the scales. Researchers have performed such links in a few cases, such as linking
the tissue and organ scales in a model of the arterial wall 171 and linking collagen matrix tissue-
scale behavior to molecular mechanics 32, 98
Heart Valve Numerical Models
Enabled by the experimental and theoretical methods described above, a number of groups are
actively developing and using mathematical models of heart valve mechanics. For each length
scale, we give a brief history of heart valve models and describe the current state of the art.
Organ Scale
At the organ scale, the motion of natural valves and bioprosthetic valves is very similar.
Accordingly, the simulation methods for the two are similar, and we discuss the two together.
Mechanical valve motion is quite different from tissue valves. Simulation of mechanical valves
is discussed here both because the impressive work in the field bears mention, and because
simulation methods developed for mechanical valves may have application for tissue valves.
Over the past three decades, simulations of heart valve motion have drawn from the existing
state-of-the art technologies and pushed for further advances. The simplest valve simulation is
the static case of a valve closed against pressure. This situation can be examined without a fluid
phase, representing the fluid simply as a pressure load against the valve leaflets. The earliest
simulations were of this case, generally treating the solid as isotropic and linear2 9' 30, 38, 85, 86
Figure 1.14 shows the geometry of a leaflet in one such simulation 85. Analysis of the static,
closed-valve case has continued1 o, and present models include rigorous accompanying work in
material modeling and experimental verification 72.
Figure 1.14. Mesh geometry for early static simulation of leaflet85
The next step in complexity of organ-scale models is to move from the static to the dynamic
case. Again, the fluid can be represented simply as a pressure load applied on the surfaces of the
solid, but now the leaflets move through large deformations. The first dynamic solid-phase
models were developed a few years after the first static models, and thus tend to include more
advanced descriptions of both geometry and material properties. Grande-Allen et al simulated
the AV including realistic asymmetric geometry and the aortic root79-8 1. Geometry of this
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simulation is shown in Figure 1.15.A. Other models added anisotropic10 6 and nonlinear16' 92
material descriptions. As with the static case, the dynamic solid-only case is presently being used
with advanced material models and relevant experimental work 10o, 10'. Results of this model are
displayed in Figure 1.15.B.
A)
B)
Figure 1.15. Results of AV dynamic, solid-only simulation with a) realistic geometry 79 and b)
realistic material model l00.
An entirely new level of complexity and computational expense is added by incorporating the
fluid and performing FSI analysis. These models were created after the solid-only models, and
thus usually include more advanced material models in addition to the fluid. Possessing realistic
geometries, well-defined fibrous material models, and the interaction of fluid and solid, these
models represent the current state of the art. The de Hart group impressively has coded fictitious
domain software to perform the FSI and included a fibrous material model 46 -48 to model a
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bioprosthetic valve. One of the results of their simulations is shown in Figure 1.16.A. Other
researchers have utilized the FSI capabilities of LS-DYNA (LSTC, Livermore CA) to simulate
various valves. Nicosia et al modeled the AV using an anisotropic elastic material model" ,
followed by the work presented in this thesis of modeling the AV with a discrete fiber model' 93
and Einstein modeling the mitral valve with a splayed fiber model 56-58' 107. The last two models
notably are verified against various experimental measures, and Einstein's model is able to
predict heart sounds56. Figure 1.16.B. shows a graphic of the mitral model. The model also
includes the chordae tendinae, not shown.
A)
B)
Figure 1.16. Results of organ-scale simulations with realistic geometries, fibrous material models,
and fluid-structure interaction. A) Bioprosthetic valve simulation4 7, B) mitral valve simulation56
i
Progress in simulation of mechanical heart valves has perhaps outpaced that of tissue valves. The
most advanced models of mechanical heart valves include FSI and include sophisticated
descriptions of blood flow. All of the FSI simulations of natural valves treat the blood as a
simple Newtonian fluid. A number of models for mechanical valves have been demonstrated that
incorporate realistic non-Newtonian fluid models for blood and predict thrombogenicity of the
valve8, 19, 35, 36, 61, 199. Some results of one of these simulations 53 are shown in Figure 1.17. We
expect that future tissue valve models will incorporate these advancements in blood flow
modeling.
Figure 1.17. FSI simulation of a mechanical heart valve 53
Tissue Scale
Modeling of valve tissue-scale mechanics has been recently reviewed60' 188, and the field
continues to progress rapidly. Valve tissue, even compared to other biological tissues, is
particularly nonlinear, nonhomogeneous, and anisotropic. Loading curves for a sample of mitral
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leaflet tissue, shown in Figure 1.18, display the anisotropy and exponential behavior typical of
heart valve leaflets.
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Figure 1.18. Loading curves for human mitral leaflet tissue40, demonstrating anisotropic and
exponential behavior
A large number of approaches exist for constructing constitutive material models, and a number
have been used to describe valve leaflet tissue. One approach for defining W is to construct it as
the sum of simple terms expected to give the correct behavior, and then fit constants to
experimental data. Li et al extended linear transverse isotropy to nonlinear to model AV
tissue1 4. May-Newman and Yin constructed a Fung-like exponential strain energy function from
the three usual strain invariants and two directional pseudo-invariants 91' 95 to model mitral valve
leaflet behavior'19. An approach used widely in modeling other hyperelastic materials and
biological tissues 15 but not, to our knowledge, in heart valve mechanics, is the unit-cell approach.
Unit-cell models base their strain-energy functions on the theoretical behavior of a unit cell of
entropic chains. The most advanced strain-energy functions for valve mechanics include fiber
splay as well as fiber direction. Such models have been constructed and fit to experimental data
for aortic 13, 14 and mitral56 valves.
Current research in continuum models for leaflet mechanics aims to create a multi-layered model
of the tissue with continuum models for each layer. As depicted in Figure 1.19, Stella et al have
surgically dissected the AV leaflet to perform biaxial testing of each layer, and based on that data
they have created a model having multiple layers with different splayed-fiber material
descriptionso .
Figure 1.19. Surgical dissection of AV cusp layers 160
Also drawing from that data, in this thesis we will model each layer with a continuum model and
add the undulated geometry and transversely isotropic behavior for each layer1 93 . The geometry
of this tissue model is shown in Figure 1.20.
Figure 1.20. Geometry of multilayered, undulated tissue model 193
A number of examples have been published where analytical models for valve tissue are
implemented for use in FEA simulations. Since the valve leaflets are fairly thin, most researchers
have used shell models. Bioprosthetic valves have been modeled with shells having aligned-
fibers models1 6' 27. Shell models have also been implemented for mitral valve leaflet tissue142
including the effect of changes in thickness' 92. Currently, the most widely used models
incorporate a splayed fiber model into a shell. This approach has been used successfully in
simulating bioprosthetic valves' 72' 173 and mitral valves in healthy and diseased states56 58s
While most existing constitutive models for AV tissue mechanics are continuum-based, in some
cases other approaches may be useful. In this thesis, we will create a discrete fiber tissue model,
illustrated in Figure 1.21, that is particularly computationally efficient when used in explicit
finite element codes such as LS-DYNA 193 .
Figure 1.21. Single solid element of discrete-fiber model for AV tissue' 93
Cell Scale
While many groups have reported simulation of organ and tissue scale heart valve mechanics
over the past three decades, simulation at the cell scale has only been reported recently by two
groups. Huang et al modeled the deformation of ICs in pressurized valves and compared results
94. Their simulation geometry
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Figure 1.22.A. In this thesis, we will extend to that work to the three-dimensional, dynamic
deformations' 93 and to disease 9° .
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Figure 1.22. Theoretical and experimental investigation of IC deformation in valves under
pressure by Huang et al. A) Simulation geometry B) Image processing measuring IC aspect
ratios
Molecule Scale
Molecular-level simulation has not yet been applied specifically to heart valve molecular
mechanics. Some efforts do exist, however, that are directly applicable. In particular, current
research is directed to simulating various aspects of the behavior of collagen fiber on the
molecule scale 139, 144-146, 162
Multi-Scale
H- 9.75 Wff-H
Researchers have presently taken up the interesting task of linking simulations between various
length scales. Different groups have chosen various multiscale effects. Carmody et al. have
embedded the valve organ-scale motion to the larger organ-scale motion of the left ventricle28.
We have previously mentioned the cell-scale simulation by Huang et al. They have used
analytical calculations to link the cell-scale model to pressures applied at the organ-scale, and
have notably compared to experimental data with good agreement 93, 94. An image from their
measurement of IC aspect ratios under pressures is shown in
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Figure 1.22.B. In this thesis we will introduce a system of reference configurations to link the
length scales' 93. Within this framework, illustrated in Figure 1.23, we will compute organ scale
motion, from which tissue scale deformations will be extracted, and tissue deformation will
similarly be translated to the cell scale. The complete model presented in this thesis is thus a
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A)
dynamic, three-dimensional simulation of AV mechanics spanning the cell, tissue, and organ
length scales.
Figure 1.23. Linking of multiscale AV mechanical simulations from the organ scale to the tissue
and cell scales' 9 3
Conclusions and Future Directions
Investigating the healthy and diseased processes in heart valves is a complex, multi-scale, multi-
disciplinary effort with important clinical outputs. Research in this field has already contributed
enormously to patient care, most notably the development of prosthetic and bioprosthetic valve
replacements. Simulation of valve mechanical behavior is a vital tool in improving valve
replacement design as well as in increasing our fundamental understanding of valve behavior.
Many researchers have modeled valve mechanics at the tissue and organ scales over the past
three decades. In the past five years, research has begun on mechanics at the molecule and cell
scales, as well as on mechanical behaviors spanning multiple length scales. Heart valve
researchers have consistently drawn on cutting edge experimental and theoretical methods and
pushed for advancements where existing tools were insufficient. A number of groups are
currently active in developing the next generation of experimental tools, numerical methods, and
mechanical simulations of the human heart valves.
Simulation of heart valves is expected to progress in a few main directions. First, models of
organ and tissue scale mechanics have gone through generations of refinement where tissue and
cell scale models are currently in their first generation. Researchers will work to bring the
smaller-scale simulations to the same level of sophistication as the larger-scale models. Models
that link the length scales are also in their infancy, and researchers will further refine multiscale
methods.
Refinement of models will surely continue, but to have significant clinical impact and to increase
our fundamental understanding of the valves these simulations must be joined performed in
concert with experimental efforts. Recent efforts combining multiscale modeling with
experiment have elucidated the deformation of ICs in response to valve motion 94 and, as
described in this thesis, the phenotypic expression of ECs in response to blood flow through the
valve1 89. Further multiscale, multidisciplinary efforts will similarly increase our ability to
understand valve function and treat valve disease.
Outline of Thesis
The goals of this thesis are to create a multiscale mechanical model of the human aortic heart
valve and to use that model in an examination of CAS. The following is an outline of the
approach taken to create and apply the model.
In Chapter 2, we develop the model. The first step is creation of a framework of reference
configurations, through which the simulations at various scales can communicate. After that,
dynamic, finite-element simulations of the cell, tissue, and organ scale mechanics are formulated.
The cell scale model simulates a single IC surrounded by matrix. The tissue scale model
describes the valve cusp as a multilayered structure, with varying thickness and with each layer
being anisotropic and nonlinear. At the organ scale, we simulate the dynamic interaction between
tissue and blood in the valve. Each individual model and the overall multiscale simulation are
verified against experimental data.
In Chapter 3, we extend this model to simulate the effect of aging on the valve, with and without
calcification. Normal aging is described by a thickening and stiffening of the cusp tissue.
Calcification is introduced at the tissue level and allowed to spread across the cusp over time.
The effect of these tissue-level changes on valve function is monitored at the organ scale, and
compared to clinically accepted indices for valvular function.
In Chapter 4, we apply the multiscale model to investigate one facet the role of solid
deformations in CAS. CAS is much more common in the abnormal, bicuspid AV than in the
normal, tricuspid valve. Since the bicuspid valve has different mechanical deformations than the
tricuspid, this provides a test case for analyzing the role of such deformations in CAS. A
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multiscale model of the bicuspid valve is developed, and the multiscale mechanics are compared
to those of the tricuspid. We find that, while organ scale deformations are significantly different,
deformations at the cell scale in the two cases are similar. This work provides evidence that
supports the argument that the difference in CAS pathology between the two valves has a cause
other than the difference in mechanical deformations.
In Chapter 5, we use a combination of simulation and experiment to examine the role of fluid
shear in CAS. An organ scale simulation is created with high resolution on the boundaries in
order to calculate the transient shears applied to the ECs. Those shears are then applied in vitro to
human ECs. We show that shear waveforms measured on each side of the cusp direct the ECs to
express different phenotypes. These side-specific phenotypes correlate well with those observed
in vivo and with the side-specific nature of CAS. This work provides evidence for the theory that
shear has an important signaling role in CAS.
Chapter 2. Transient, three-dimensional, multiscale simulations
of the human aortic valve
Introduction
Biological processes in both the healthy and diseased aortic valve (AV) occur over a range of
length scales. Cells within the valve cusps, the valvular interstitial cells (ICs), are understood to
sense and respond to mechanical stimuli. The ICs are subjected to transient deformations due to
the organ-scale motion of the valve opening and closing. Currently, we understand that in
healthy valves the transient deformations regulate appropriate matrix-maintaining functions of
the ICs 7 . In diseased states, particularly in calcified valves, it is thought that abnormal
mechanical signals lead to IC dysfunction 34. Additionally, calcification of bioprosthetic valves
is believed to be a local effect of cusp deformation. As the health and repair of heart valves is of
great clinical importance, significant research has been conducted to examine the mechanical
behavior of the AV at each length scale.
The organ-scale motion of the AV has historically attracted significant attention from
experimental and theoretical groups. Over the past three decades, many methods have been
employed to monitor the motion of the AV. Its small size and rapid motion make measurements
challenging, but imaging technologies have recently demonstrated the acquisition speed and
resolution to discern valve motion', 20. Earlier efforts have measured valve motion using
surgically attached linear transducers 23 and radio-opaque markers49, 180, 182
stereophotogrammetry 41, and silicone casting2 9' 30, 78
A number of groups have used finite-element modeling to simulate the motion of the AV. There
are two main challenges in creating a finite-element simulation of a heart valve. First, the leaflets
undergo large displacements through the blood, making remeshing of a fluid domain difficult for
a coupled fluid-structure interaction. While fluid-structure interactions are generally approached
using the Arbitrary Lagrange-Eulerian (ALE) coupling scheme, we are not aware of any work
that successfully applies this method to a 3D valve simulation. The second challenge in
simulating valve motion is that the material is anisotropic and nonlinear. Kim et al have modeled
the valve motion with a specifically derived material model, but without the fluid phase 99' 100. De
Hart et al have implemented a fictitious domain method for coupling the fluid and solid without
remesh of the fluid domain, and they have used this method to simulate the motion of the AV
cusps with a fiber-supported constitutive material model4 6-48 . The finite element package LS-
DYNA (LSTC, Livermore CA) includes the operator-splitting method which similarly couples
solid to fluid without remeshing the fluid domain84 . This software has been used to perform
fluid-structure interactions of the AV, including the motion of the aortic root, with an anisotropic
linear elastic material model131 and to simulate the mitral valve with a user-defined fibrous
material model 56, 57. A number of groups have simulated the valve solid without fluid or under
quasistatic conditions. Sun provides a full list of such efforts1 72 .
A large body of research also exists in the measurement and simulation of the mechanical
properties of AV tissue. The planar stress-strain behavior of complete tissue 13, 41, 151 and
individual layers 6  186 have been measured as has the flexural stiffness of the tissuel 54
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Merryman et al have measured the effect of cellular contraction on the overall tissue material
properties 22. Various appropriate constitutive models have been formulated' 4' 91 and
implemented in solid and shell finite elements 99' 73, 191, 192
Modeling of cell-scale deformations in general is an active area of research 16 , but investigations
specific to the ICs are in the preliminary stages. Merryman et al have measured the stiffness of
ICs'2 3 and Huang et al have computed the deformation of ICs in valves subjected to static
pressure93
While the mechanical behavior of the AV at the various length scales is a subject of wide
interest, and multiscale analysis of other systems has been performed3 2' 124, as of yet no effort has
been made to cohesively bring together studies of the AV over the range from cellular to organ
length scales. Understanding of all these processes will be greatly enhanced by a coherent
framework for examining the deformations of the AV at the various length scales. In this
chapter, we introduce a system of reference configurations to link the length scales. We describe
finite-element simulations of AV mechanics at the cell, tissue, and organ length scales. Each
simulation considers the transient, three-dimensional case with appropriate material models and
geometry. The complete set of simulations enables unprecedented analysis of the AV behavior
across the range of length scales from cell to organ.
Methods
Multi-scale approach
Simulations were created to describe behaviors at the cell, tissue, and organ length scales. One
challenge in describing AV mechanics is that the tissue goes through a wide range of
deformations and these deformations may be referred to a range of reference configurations.
Stella1 60 and Billiar 14 have demonstrated the large difference in results possible when different
reference configurations are assumed. In order to coherently link our simulations, we have
defined a set of reference configurations. Our configuration definitions extend those of Stella160
These configurations are summarized in Table 2.1. In £20, the ventricularis and fibrosa are
unattached and stress-free. The layers are connected to form the assembled tissue 21. In Q2, the
tissue is in position in a valve to which no pressure has been applied. When the valve is
pressurized to its resting physiological state, the tissue is in 03. We denote the time-varying state
of the tissue in the functioning valve as 2t.
Table 2.1. Tissue reference configurations
Symbol Schematic Description Extensibilities
fibrosa: A;c= 1.10, 2,= 1.40
unattached layers
ventricularis: Ac= 1.20, 4R= 1.90
r -I 1 1 
-1
fibrosa: A,c= 1. 10 , R = 1.40
assembled tissue ventricularis: Ac= 1.20, AR= 1.70
tissue: A, = 1.10, A•= 1.70
-P£2 ()(J• tissue in valve with no
external forces applied tissue: 10, 1.25
tissue in valve with
baseline pressure applied tissue: At= 1.05,A= 1.20
t tissue in functioning valve tissue, mn id-diastole: ,.' = 1.00,(A AR= 1.00
Q t
Q I
The leaflet tissue exhibits locking behavior, where the stress needed to extend the tissue
increases rapidly beyond some point. We define the extensibility of the tissue to be the stretch
that can be applied to the tissue before the Cauchy stress exceeds 200KPa in the direction of
application. The extensibility of the leaflet tissue in each reference configuration, in both the
circumferential and radial directions, can be determined from published experiments. The
measured extensibilities of individual layers referred to Qo are listed in Table 2.1160. Stella's data
show an increase in radial extensibility for the fibrosa from o20 to Q21. This increase is most likely
due to the fibrosa being compacted into a wrinkled shape. We include the wrinkling effect in our
models, so we assume that the fibrosa material has the same radial extensibility 21, as in Q0. The
extensibilities of the assembled tissue referred to 21, were estimated to be 1.7 in the radial
direction and 1.2 in the circumferential direction' 3. The extensibilities referred to the valve
configuration Q22 are determined by assuming that the tissue reaches its locking stretches in both
directions in diastole. The stretches at diastole have been measured 29, 179 to be 1.25 in the radial
direction and 1.1 in the circumferential direction. The extensibilities referred to Q23 are not known
a priori. For illustrative purposes, we assume that a small stretch (1.05) is applied to the tissue in
both directions between Q22 and Q23. The magnitude of the stretch occurring between 22 and 23
will be calculated in the organ-scale simulation.
Once the extensibilities are known, we can calculate the stretches that are applied to the tissue in
each configuration. With those stretches, we can begin at any configuration and calculate the
stretches required to reach any other configuration. In
Figure 2.1, the stretches required to move from G20 to all other configurations in sequence are
plotted. Note that a large stretch in the radial direction between Q21 and £22 is required to reconcile
the measured extensibility of completely load-free tissue' 3 with the observed extensibility of
tissue in a functioning valve29' 179. Thus, we are assuming that leaflet tissue, in an AV with no
external forces applied, has tension in the radial direction. The stretch less than 1 in the radial
direction for the fibrosa represents the wrinkling of this layer when the fibrosa and ventricularis
are attached to each other.
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Figure 2.1. Cumulative stretches required
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We create our multiscale simulations within the framework of these reference configurations.
For each simulation, a reference configuration is chosen and the simulation geometry and
constitutive models are referred to that configuration. The simulations are listed in Table 2.2 with
their length scales, reference configurations, and the configurations that they span.
Table 2.2. Simulation scales and configurations
Simulation Feature Size Reference Configurations
Range Configuration Simulated
Cell-scale 2p - 501. f22 02- f2t
0o9
a)
21
----- i
i
i
These simulations are interfaced by a simple one-way coupling, passing data from the largest
scale to the smallest. First, the organ-level simulation is run. Element strains output from the
organ-level simulation are applied as boundary conditions to the tissue-level simulation. Then
strains from the tissue-level simulation are passed similarly to the cell-level simulations.
Organ-level simulation
The organ-level simulation was performed in LS-DYNA. This software was chosen because its
operator-splitting method for fluid-structure interaction has been demonstrated to readily handle
the motion of a solid through fluid typical of heart valve function, 131. LS-DYNA is an explicit
solver, which means it may require excessive computation times in modeling relatively low-
speed physical systems such as the AV. We address this issue in our formulation of the
constitutive model used to describe the cusp tissue mechanics.
To simulate the cusp mechanics, we have developed a constitutive model that describes the bulk
material behavior and is particularly computationally efficient in explicit finite element codes.
Like many tissue constitutive models 14, 91, 95, 173, ours treats the tissue as an isotropic solid with
embedded aligned fibers. Instead of using a continuum model, though, we take a discrete
approach. The solid mesh elements are modeled with an isotropic material. One-dimensional
cable elements are then used to connect the nodes of the solid element. LS-DYNA allows
assignment of arbitrary stress-strain curves to the cable elements, and fiber rotations follow nodal
displacements. A single element with this model is illustrated in Figure 2.2. Red cylinders
represent fibers of one family and blue represent fibers of another family, perpendicular to the
first.
Figure 2.2. Single solid element with two perpendicular fiber families
Appropriate stress-strain curves and cross-sectional areas must be chosen for each fiber. It is
assumed that the fibers contribute no stiffness in compression. There is some flexibility in
choosing the magnitude of the stresses and the cross-sectional area of the fibers. If an element
with fibers along each edge is extended in a direction parallel to those fibers, the stress
contribution of the fibers to total element response is
4 orfA,
Ae (Eq. 2.1)
whereaf is the stress in each fiber, Af is the cross-sectional area of each fiber, and Ae is the
cross-sectional area of the solid element. Thus, a c should have a value corresponding to
measured tissue properties and Ae is determined by the mesh density, but the ratio of arf to Af
can be arbitrary. This property can be utilized to enhance the computation speed when using the
discrete fiber model in an explicit finite element code. In the explicit method, the maximum
allowable time step is decreased as element stiffness is increased. Because in our model the
greatest stiffness is found in the fibers, these will control the maximum time step. In a one-
dimensional element the maximum allowable time step is
Atmax = L (Eq. 2.2)
where L is the length of the element, p is the density of the element, and E is the maximum
material modulus84 . The stiffness of a nonlinear cable element at a given strain Eo
E = (Eq. 2.3)
As such, a fiber can be defined with artificially high cross-sectional areas Af and corresponding
artificially low stress cr . The resulting element will have low stiffness E, and thus allow large
timesteps, while still giving the correct overall element stress c c.
The discrete fiber model was implemented in LS-DYNA. The constitutive model was
constructed referring to the tissue configuration •22. The isotropic solid was modeled as a single-
term Mooney-Rivlin with the value C1= 2.0e4 chosen to fit bending data for the leaflet154 . The
stress-strain curves in the radial and circumferential direction measured experimentally for
configurationQ2 2160 were discretized and applied to the fiber elements. Curves for a c were fit to
the data and curves for o, were calculated using
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(Eq. 2.1)
and a value of 1.0e-3 m2 for Af. The aortic root was assumed to be anisotropic and modeled
with a single-term Mooney-Rivlin material. A value of Cl=1.0e5 was fit to experimental
pressure-versus-dilation data for the root" 1
Geometry of the AV was created in SolidWorks (SolidWorks, Concord MA). Separate loft
features were used to represent the root and cusp. Dimensions were determined from collected
measurements of the gross geometry179 and varying cusp thicknesses79 . Cusps were positioned in
an unloaded configuration that, according to observations of explanted valves made in our lab,
best represents the unloaded configuration £22. Figure 2.3.A shows the 3D geometry of the valve,
with colors representing the separate loft features. Perfect symmetry of the valve was assumed so
that only one-sixth of the valve needed to be considered for simulation. Entry regions were added
both to allow the root to move freely while the portions of the wall at the inlet and outlet remain
fixed to the stationary fluid sources. The solid domain consisting of valve, root, and entry regions
was embedded in a cylindrical fluid domain with source regions representing fluid interface with
the ventricle and aorta. Figure 2.3.B shows the simulation geometry with 1/6 symmetry, entry
regions, and fluid. Parametric 8-node brick meshes of both the solid and fluid domains were
created in TrueGrid (XYZ Scientific Applications, Inc., Livermore CA). Figure 2.3.C shows the
meshed geometry.
Lx , I4III ~ I I, P
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Figure 2.3. a) CAD geometry of whole valve b) CAD simulation geometry c) meshed geometry
Cable elements representing circumferential and radial fiber families were overlaid on the solid
mesh using HyperMesh (Altair Engineering, Troy MI), following observed fiber directions 58.
The fiber families are illustrated in Figure 2.4.
n) V)
Figure 2.4. One cusp, with a) experimentally measured fiber orientation 158 and b) discrete fibers
overlaid on the solid mesh. Red represents circumferential fibers and blue represents radial.
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Fixities and boundary conditions were applied to the mesh. Mirror conditions were applied to
fluid and solid nodes on the two symmetry planes. The unattached ends of the entry regions were
fixed while the nodes at the junction of the entry regions and the aortic root were constrained
from moving axially. Outer faces of the fluid domain were not constrained.
Two cases were run in the organ-scale simulation, a static and a fully dynamic case. In the static
case, constant pressures of 0, 1, 2, 4, 60, and 90 mmHg were applied at the aortic inlet
sequentially. A settling time of 0.3 seconds was allowed at each pressure level. Pressure at the
ventricular inlet was kept at OmmHg and ventricular contraction was not applied in the static
case. In the dynamic case, measured time-varying pressures for the aorta and ventricle179 were
applied as boundary conditions to the fluid sources. The pressure values are plotted versus time
in Figure 2.5.A. Contraction of the ventricle was represented by applying an experimentally-
derived11o time-varying radial displacement to the base of the AV. The applied dilation of the
base is plotted in Figure 2.5.B. In Figure 2.5, the time from -0.3 < t < 0 represents the
pressurization of the valve from configuration Q2 to Q3. Configuration Qt is any state where t >0.
Systole occurs for approximately 0 < t < 0.25 and diastole for 0.3 < t < 1.0. All temporal plots in
this paper are referred to this timeframe.
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Figure 2.5. a) Pressure versus time curves applied as model boundary conditions b) Dilation of
AV base applied as model boundary condition
Results of the organ-level simulation were processed in HyperView (Altair Engineering, Troy
MI). The model was verified by comparing a number of behaviors in the solid and fluid to
experimental data. Element deformations were tracked at three locations for mapping to the
tissue-level simulation. These three locations are illustrated in Figure 2.6.
Figure 2.6. Locations to track deformations in the organ-scale simulation
Tissue-level simulation
In the organ-level simulation, we use a greatly simplified model of the cusp tissue. This
simplified model gives the correct bulk behavior (bending and biaxial stiffness), but does not
predict local tissue deformations. In order to predict the local deformations, we developed a
tissue model that incorporates all of the major known features of the cusp tissue. These
characteristics are: the cusp has three distinct layers (the ventricularis, spongiosa, and fibrosa),
the fibrosa and ventricularis have embedded families of aligned fibers, the fibrosa is highly
undulated, and the spongiosa is gel-like.
We created the tissue-level model in the ADINA implicit finite-element software (ADINA R&D,
Watertown MA). Computational cost is not a concern so, unlike in the organ-scale model, we
can use continuum material models. We considered the fibrous layers to be composed of an
isotropic exponential material with a family of embedded exponential fibers running in the
circumferential tissue direction. Additionally, bending data 154 show that the tissue has an initial
modulus.
We modeled the isotropic exponential material with a single-term Fung-like exponential 72. The
strain energy function for this term is
Weponential =CIm {exp [C 2m I, - 3)] -1 (Eq. 2.4)
where Cim and C2m are constants that will be calculated from experimental data and I, is the first
strain invariant. We provide an initial modulus with a single-term Mooney-Rivlin, for which the
strain energy function is
WinitiaI - C, (, - 3) (Eq. 2.5)
where C, is a constant that will be calculated from experimental data. The embedded fiber family
is modeled using the Holzapfel model91,
C xp(Eq. 2.6)
iber= C2f 2C4 - 32
where Cif and C2f are constants that will be calculated from experimental data. The complete
strain energy function for a fibrous layer is a sum of the terms above,
W C, {expP[C 2m (I -3)]-1}+C,(1-3)+ xp[C2f( 4 -3)2]-1 (Eq. 2.7)
2C2f
We modeled the spongiosa with a single-term Mooney-Rivlin strain energy function.
The fiber layers are described by five constants: CI, C1m, C2m, CIf, and C2f. We calculate these
values from experimental data. Sensitive measurements of the tissue flexural stiffness simply
give the initial modulus. We assume that the initial modulus is the same in the ventricularis and
fibrosa and that the stiffness of the spongiosa, which is much more compliant 86, is an order of
magnitude lower.
Constants of the exponential terms were determined from biaxial stress-strain data for the
individual layers'16 . Two values were extracted for both the radial and circumferential tissue
directions. A locking modulus EL is defined as the Young's modulus in the direction of interest
when the tissue reaches full extensibility in that direction. The extensibilities and locking moduli
in the circumferential and radial directions are adequate to analytically solve for the four
remaining constants, C1m, C2m, Clf, and C2f. The extensibilities, moduli, and determined
constants, are listed in Table 2.3. We have calculated the constants referred both to configuration
Q0 and Q21.
Table 2.3. Tissue layers and properties in configurations Qo and Q•
E
4') C
SLi
x 0
o C CI Cim C2m Cf C2f
[-] [-] [Pal [Pa] [Pal [Pal [-1 [Pal [-]
Co 1.1 1.4 2.6e7 1.1e7 2.0e4 0.95 1.4e3 0.04 24
0 x 1.1 1.4 2.6e7 1.1e7 2.0e4 0.95 1.4e3 0.04 24
Do 1.2 1.9 1.6e 5.0e6 2.0e4 2.5e-5 1.1e2 0.04 5.4I-c
-I
. DR 1.2 1.7 1.6e7 5.0e6 2.0e4 2.5e-5 1.le2 0.05 5.7
Geometry for the model of assembled tissue, configuration Q1, was created in SolidWorks. The
dimensions are based on measurements of tissue thickness 160,' 186 and observations of tissue cross-
sections.
2 1
• 4
c) N3
2.7.A shows a micrograph cross-section
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of valve cusp
Figure
tissue, and
IFigure
2.7.B, the meshed CAD representation of this geometry. Material properties from Table 2.3 were
assigned to the appropriate layers in configuration Q1. Biaxial stress and bending conditions were
applied to the assembled tissue, and the results were compared to experimental data13' 154. Each
term in (Eq. 2.7) is convex over a wide range of deformations, so the complete equation was
also expected to maintain convexity. We examined convexity on the ventricularis and fibrosa
models by calculating the strain energy over a wide range of biaxial conditions.
I
N.
a :
Figure 2.7. a) micrograph of AV leaflet cross-section' 74 b) meshed model of AV leaflet c)
locations for deformation tracking
We used the model of the multilayered tissue referred to configuration Q1 to map deformations
from the organ-scale model to the cell-scale model. First, a radial stretch was applied to move the
tissue from configuration Q21 to £22, its position in the unpressurized valve. Then element strains
measured in the organ-level simulation, which covers configurations 22 through Qt, were applied
as time-varying displacement boundary conditions to the tissue model. Deformations at points
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ventricularis and fibrosa,
N;
Figure
2.7.C, were tracked and passed on to the cell-level simulation. Point 1 is in an expected high-
deformation region of the fibrosa, Point 2 is in an expected low-deformation region of the
fibrosa, and Point 3 is in the ventricularis. Mapping was performed for both the static and
dynamic cases.
In addition to the model of the multilayered tissue, we have modeled the assembly of the tissue
(transition from Q0 to 21) with the observed preloading between fibrosa and ventricularis' 84' 185
A model fibrosa with mechanical properties referred to £2o was compressed and a fibrosa
stretched using the values plotted in Table 2.3. While this model was not used in our current
multiscale approach, it does allow prediction of deformations over the entire range from Qo to 2t.
Cell-level simulation
The cell-level simulation consists of a single cell surrounded by matrix, either fibrosa or
ventricularis. Constitutive models for the matrix are the same as those for the tissue-level model.
The constitutive model for the cell is a single-term Mooney-Rivlin with C1=400 Pa93
within the shown in
I
Geometry was created in ADINA. A sphere was created within cube and then scaled in the three
dimensions to give the cell an ellipsoidal shape. According to experimental measurements 93, the
major axes of this cell were defined to be 10pm in the circumferential direction, 7.7itm in the
radial direction, and 4.3itm in the transmural direction. Three planes of symmetry were defined
so that the computation domain consists of 1/8th of the cell and matrix. The simulation geometry
is shown in Figure 2.8.
Figure 2.8. Meshed geometry for cell-scale simulation. Cell is colored red and matrix is gray.
Displacement boundary conditions were applied to the outer faces of the matrix. These
displacements were defined to represent the element strains calculated in the tissue-level
simulation. Because the relevant experiments 93 start with the valve in a zero-pressure state, we
started our cell simulations in the unpressurized valve configuration Q2 . Cell aspect ratio (CAR)
was output from the simulation. The model was verified by comparing results of the static case
to experimental CAR measurements made under the same conditions 93. Cell aspect ratio was
also computed for the dynamic case of valve opening and closing.
Results
Organ-level simulation
The discrete fiber constitutive model was found to be adequate in predicting the bulk
deformation behavior of the tissue. Figure 2.9.A shows the biaxial response of this model and
Figure 2.9.B shows the bending response. Because we are not aware of any experimental data for
tissue properties referred to the assembled valve configuration £22, we could not construct this
model to match a specific case. Note, though, in Figure 2.9.A the similarity between our model
predictions and the measurements made by Billiar referred to a lightly preloaded configuration 3.
This enforces the notion that the tissue exists in a lightly preloaded state in the valve.
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Figure 2.9. Discrete fiber model predictions and experimental results: a) predicted biaxial
behavior and experimental data for a lightly preloaded case 13 b) predicted bending behavior and
the experimental data 156 to which the model was fit
One second of physical time, representing either the full static case or one dynamic cycle of
valve opening and closing, ran in approximately 3 hours of computation time on a workstation
with 4 Xeon 5160 3.00 GHz processors. There was no leakage in the fluid-structure interaction,
and the cusps coapted and sealed against flow. Figure 2.10.A shows the valve in various stages
of the dynamic cycle.
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Figure 2.10. Selected deformed states in each dynamic simulation
For the dynamic case, theoretical predictions matched experimental data in a number of
measures. In the fluid phase, the bulk flow rate through the valve closely corresponded with
experimental data130 . Velocity profiles predicted at various times across the AV outlet are
compared to experimental measurements in Figure 2.11. Theoretical and measured flow rates are
plotted versus time in Figure 2.12. In the solid phase, predictions were compared to experimental
data for cusp edge and center displacement, circumferential strain, radial strain, and root
motion 179. These results are plotted in Figure 2.13. In the fluid and solid phase, predictions
display all major trends with correct magnitudes when compared to measured data. Error
00000
organ-level cell-level
magnitudes are acceptable given patient-to-patient variation, beat-to-beat variation, and
experimental errors inherent in measurement of the rapidly moving in-vivo system.
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Figure 2.11. Predicted and measured velocity profiles at AV exit. a) shows profiles while the fluid
is accelerating flow and b) during deceleration
X
"-`, -"'
Wf
time [s]
Figure 2.12. Predicted and measured flow rates through AV
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Figure 2.13. Predicted and measured' 79 motion of valve leaflets: a) circumferential leaflet stretch
b) radial leaflet stretch c) displacement of points at edge and middle of leaflet
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Element stretches averaged over the locations illustrated in Figure 2.6 for the static case are
shown in Figure 2.14. Deformations recorded in the dynamic case for location B shown in Figure
2.6 in the dynamic case are plotted versus time in Figure 2.15. Stretches for t<O represent the
unknown stretches between reference configurations 0•2 and 23 discussed earlier in this chapter.
The dominant deformations were the tensile stretches in the radial and circumferential directions
and the bending in the radial direction. In the tracked locations, shears in and out of the plane of
the tissue as well as bending in the circumferential direction tended to be small and were not
mapped to the tissue-level model.
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Figure 2.14. Element stretches predicted in static case
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Figure 2.15. Element deformations predicted in dynamic case versus time: a) planar stretches b)
curvature
Tissue-level simulation
All tissue-level simulations ran to convergence over a range of strains larger than is expected to
be seen physiologically. Contour plots of the strain-energy surfaces for the fibrosa and
ventricularis models are shown in Figure 2.16. For visualization of the wide variation in energies
of these exponential functions, we have plotted log(W). Convexity was maintained in all tested
cases. The responses of the fibrosa and ventricularis model to biaxial tension are plotted in
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Figure 2.17. The predicted biaxial and bending behaviors of the complete tissue model compared
to experimental 154, 160 are shown in Figure 2.18. We note a discrepancy in the experimental data
for the circumferential direction between the individual layers (Figure 2.17)160 and the assembled
tissue (Figure 2.18)13: the assembled tissue is more extensible than the fibrosa in this direction.
Hence, our model matches the data for individual layers well and underestimates the extensibility
of the assembled tissue compared to this data set. The smaller value of the extensibility is
consistent with stretches observed in the functioning valve 29, 30, 182
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Figure 2.16. Contour plots of log( W) for continuum model subjected to biaxial loading
conditions: a) fibrosa model b) ventricularis model
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Continuum model predictions for the assembled tissue, referred to configuration DI,
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Radial stretches due to assembly of the layers into a complete tissue (deforming from 20 to I-1)
are shown in Figure 2.19. Deformation states for the tissue model subject to strains measured in
the organ-level model are shown at various times in Figure 2.10.B. Stretch magnitudes predicted
in the static case are plotted in Figure 2.20. Stretches recorded in the tissue model for the
dynamic case are plotted versus time in Figure 2.21.
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Figure 2.19. Radial stretches due to assembling layers into complete tissue.
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Figure 2.21. Stretch magnitudes predicted by tissue-scale model versus time at location B
illustrated in Figure 2.6 for the dynamic case
Cell-level simulation
All cell-level simulations ran to convergence. Deformation states for selected locations at various
times in the cycle are illustrated in Figure 2.10.C. In Figure 2.22, cellular aspect ratios predicted
* point 1
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* point 3
60 90 b2 4pressure [mmHgl
II
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for the static case are compared to measurements 93 made under static pressure. Values at points
1, 2, and 3 are plotted. The experimental data is an average over the leaflet, so we have also
plotted the average over points 1, 2, and 3. The variation in CAR through the leaflet thickness
and with varying pressure is compared to experimental data 93 in Figure 2.23. In both
comparisons, the predictions closely match the experimental data. In the dynamic case, we have
computed the time-varying aspect ratios for the three points tracked in the tissue-scale simulation
at the three locations tracked in the organ-scale simulation for a total of 9 points. To give a
typical response, we have averaged together the cellular aspect ratios for point 1 (see
-1
C)
Figure
2.7.C) of locations A, B, and C (see Figure 2.6). We have done the same for points 2 and 3. The
results are plotted in Figure 2.24.
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Figure 2.22. Predicted cellular aspect ratios compared to experimental measurements 93 for the
static case
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Figure 2.23. Predicted distribution of cellular aspect ratios through leaflet thickness compared to
experimental measurements 93 for the static case. Normalized thickness varies from the
ventricularis surface at 0 to the fibrosa surface at 1.
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Discussion
Organ-level simulation
A number of assumptions were made to simplify analysis of the valve motion. First, a 1/6
symmetry was assumed for the valve. In reality, there is at least a difference between the
coronary and non-coronary sinuses and cusps. It has been shown that the asymmetry does create
different strain states in leaflets of the same valve 81 . However, these differences are small
relative to the large displacements and strains that take place in the valve. The experiments to
which we have compared our predictions generally do not note a difference between leaflets1 79,
hence the effects of asymmetry are finer than the current work can resolve. A coarse mesh was
used, particularly in the fluid phase, to decrease computation time. Prediction of finer features of
the fluid and shears within thin boundary layers would require a refined mesh.
Equally important simplifications were made in the choice of material model used. We assumed
that both the leaflet and wall materials are homogenous and that the leaflet fiber directions can be
represented simply by two fiber families. Both the leaflet' 58 and wall"o0 have been shown to be in
inhomogeneous, and the leaflet fiber distribution varies throughout the leaflet and changes as the
tissue deforms' 58 . There does not currently exist, however, a complete map of material properties
to the valve geometry. For example, the leaflet material properties have been accurately
measured in-vitro' 3 , but the effects of physical preloads and cellular contraction 22 in-vivo are
undetermined. The discrete-fiber model simulates the main features that we currently understand
to be important to the tissue bulk deformation.
Other simplifications include our smooth CAD representation of a complex biological geometry,
representation of the ventricular contraction as a simple displacement condition, and lack of
tissue surrounding the aortic root. The organ-scale model is clearly an idealization of the
physical case. Comparison of the model to experimental data for both the fluid and solid domains
shows that the model capably represents the valve motion in both domains.
Tissue-level simulation
The purpose of the tissue-level simulation is to translate deformations from the organ scale to the
cell scale. Since the AV cusp tissue is multilayered and undulated, the tissue model must also
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have those characteristics in order to accurately predict the cell-level deformations. While the
bulk properties of the tissue have been widely reported, the details of the interplay between
layers and motion of the undulations in the fibrosa as the tissue deforms are not known. Our
tissue model simulates the major bulk behaviors of each layer and of the complete tissue but the
local behaviors are, at this time, speculative. Experimental investigation into the local
deformations of the AV tissue could be used to verify this work. Currently, the tissue model
accurately represents bulk tissue behavior and approximates local behavior to the highest
resolution possible given available knowledge.
Cell-level simulation
Our model of the mechanics of ICs in the leaflets is highly simplified. Both the matrix and cell
are modeled as homogenous solids. Actually, the fibrous nature of the matrix is evident at the
cell scale and the cell has multiple solid and fluid components. The features of the matrix and
cell have not been determined beyond what we have included in our model, though. Given the
series of assumptions made across the simulations, the predictive ability of the cell-level
simulation demonstrated in the static case is remarkable. Our model predicts both the trend and
magnitude of change in CAR with pressure as well as the variation across the leaflet thickness.
These results give a high degree of confidence in the predictions for the dynamic case.
Conclusions
We have created three models for AV mechanics, one at each of the cell, tissue, and organ length
scales. The individual models capture the major known mechanical aspects at their respective
scales. We have demonstrated that each model is numerically functional and satisfactorily
matches experimental data. Each model represents a significantly simplified version of the
physical AV, and they all can be refined by coordinating with further experimental work.
We have introduced a coherent set of reference configurations to link the three models so as to
create one multiscale simulation of the complete mechanics and motion of the AV. We have
verified our multiscale model in the static case, which simulates a multiscale experiment that has
been previously performed. In this case, the input to the model is made at the organ scale
(pressure boundary conditions). Deformations pass through the length scales and the output is
observed at the cell scale (cell aspect ratios). We have demonstrated the ability of our approach
to accurately handle the multiscale behavior in the static case, providing confidence in the
predictions for the dynamic case.
Our multiscale model has application in studying both the healthy and diseased AV. In
particular, the disease calcific aortic stenosis has a multiscale mechanical pathology. One of the
causes of CAS is understood to be abnormal tissue strains giving rise to abnormal IC responses,
leading to calcification. This process can be examined using the multiscale model we have
presented. The effect of the disease is a stiffening of the matrix material, and our model can
simulate stiffening at all three length scales. We expect that multiscale simulation of the AV will
be a valuable tool to be used alongside experimental work to better understand AV health and
disease.
Chapter 3. A computational model of aging and calcification in
the aortic heart valve
Introduction
The aortic valve (AV) physically changes over time in all patients. Normally, this aging is
restricted to a thickening1 6 1 and loss of extensibility39, which lead to slightly impaired valve
function as the patient ages. In addition to the normal changes, the valve may change due to
pathological processes. The most common disease of the AV is calcific aortic stenosis (CAS),
found in 2% of individuals over 65 years and 4% over 8542. Early atherosclerosis-like lesions are
found in almost all adults'0 8 . In CAS, these lesions develop first into small calcified nodes. The
nodes grow over time, radically stiffening the valve leaflets. Stiffening hampers both the AV's
ability to open in systole and close in diastole. CAS is the leading cause of valve replacement,
accounting for a majority of the approximately 300,000 valve replacement surgeries worldwide
each yearl 97
Overall valve function is driven by changes of at the tissue level: stiffer, thicker tissue causes the
valve to be less efficient. Beyond increasing the general understanding of valve function, there
are two ways in which a model that describes the connection between tissue properties and valve
function will be clinically useful. First, such a model can be used in conjunction with existing
imaging techniques to improve diagnostic criteria and to aid in making decisions regarding
timing of existing surgical therapies. Second, a model can be used to quantify the effects and aid
in the design of treatments aimed at preventing CAS onset and delaying valve failure once CAS
is present.
Currently, the most common treatment for CAS is to replace the entire natural valve with a
transplanted, mechanical, or bioprosthetic valve. Timing of this procedure is critical1' 196. A
diseased valve must be replaced before full failure, but replacement valves have their own
drawbacks and should not be implanted too early1' 133, 135, 136. Main drawbacks are that tissue
valves can wear out and require re-surgery, and mechanical valves require the patient to be on
anti-coagulation therapy ' , 136, 165. Methods presently used in decision-making for valve surgery
involve examination both of the valve function and the state of the tissue. Valve function is
evaluated by using chest imaging to measure various properties of blood flow 4' 5, 60, 69 and various
geometric parameters of the valve11' 21, 183. Calcification is examined by cardiac catheter21' 141 or,
more recently, chest imaging 4 . A model that incorporates both valve function and tissue health
could aid in predicting the course of disease and in deciding when to intervene.
In addition to aiding decision-making regarding existing procedures, a model of calcific disease
can be useful in examining and designing emerging methods. Since the loss of valve function is
due to tissue dysfunction, treatments to prevent or slow disease progression must target the
tissue. Current options are for preventing the onset of CAS or valve failure are limited.
Pharmaceutical approaches do show promise in slowing the progression of CAS: in particular,
statins have been shown to do so in patient studies 150 . Balloon valvuloplasty is a surgical option,
where a balloon catheter is used to break up mild calcification, relieving stenosis. The valve
normally becomes restenosed, however, within a year, and balloon valvuloplasty is not generally
recommended 21. A better understanding of the tissue-based nature of CAS progression will
enhance our ability to develop new pharmaceutical and surgical treatments.
In this chapter, we create a model for valve aging which describes the impact of changes to tissue
properties on valve function. In the previous chapter, we described a simulation of the healthy
aortic valve spanning the cell, tissue, and organ length scales1 93, where we modeled the valve at
one adult age. In the present chapter, we extend the simulation to model the effects of aging over
the range of ages from 0 to 80. This collection of simulations yields a model of aging in the
aortic valve multiscale in both length and time, including calcification, over an individual's entire
lifetime.
Methods
We have previously described methods for using finite-element simulations to model the
mechanical behavior of the normal aortic valve1 93 and bicuspid aortic valve1 90 over the cell,
tissue, and organ length scales. These simulations have modeled the valve at one age in
adulthood. In this paper, we extend our model of AV organ-scale mechanics to describe the
transient effects of aging on the valve.
Here we briefly describe the method for modeling a healthy adult valve. Details on the
development and validation of this model can be found in"19 . Valve geometry was created in
SolidWorks (SolidWorks, Concord, MA). Dimensions of the overall valve structure 179 and
thicknesses at various locations79 were taken from literature. The geometry was meshed with
brick elements using TrueGrid (XYZ Scientific Applications, Inc., Livermore, CA) and
91
modified, including the addition of cable elements, using HyperMesh (Altair Engineering, Troy,
MI). The cable elements are part of the discrete fiber model we developed1 93 to model the highly
nonlinear, anisotropic material behavior of the leaflets in a computationally efficient manner.
Sinuses were modeled as isotropic and rubber-like, and blood was modeled as a simple
Newtonian fluid. Dynamic pressure boundary conditions, representing the pressures in the left
ventricle and aorta entrance, were applied to the blood at the valve orifices. A dynamic
displacement boundary condition was applied to the ventricular orifice to represent ventricular
contraction. The simulation was run in LS-DYNA (LSTC, Livermore, CA), which readily
accepts large displacements of the solid through the fluid utilizing an operator-splitting
algorithm 84. Models were post-processed in HyperView (Altair Engineering, Troy, MI).
To simulate normal aging of the AV, individual simulations were created representing the valve
at ages between 20 and 80 years at 10 year intervals. We are modeling the effects of aging on the
adult valve, and have not included the ages from 0 to 20 where the young valve grows and
remodels appreciably. Thicknesses were varied according to experimental data161 . Thickening
versus age data is shown in Figure 3.1.A and resulting CAD geometries of the valve at age 20
and 60 years are shown in Figure 3.1.B.
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Figure 3.1. Changes in valve geometry with age. a) Measured thickness' 6' and b) CAD geometry
at ages 20 and 60 years
Material properties were also varied following experimental data. The only known data for
leaflet stiffening versus age is that measured by Sahasakul 61 , plotted in Figure 3.1 .A. We have
previously discussed at length the choice of extensibilities in our model for the healthy AV1 93
Here, we consider that model to represent age 20. For all other ages, we scale the extensibilities
proportionally following the linear fit illustrated in Figure 3.2.A. In Figure 3.2.B, we plot the
resulting radial and circumferential stress-strain curves at ages 20 and 60.
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Figure 3.2. Changes in leaflet extensibility with age39 a) Measured radial extensibility versus age
and b) Circumferential and radial extensibilities used in model at ages 20 and 60
Progression of CAS in the AV was modeled by adding calcified zones to the valve. Initiation
sites for calcification were defined at the regions of high flexure according to observations of
explanted specimens, along the lines where the leaflet attaches to the sinus and where the free
section of the leaflet meets the coapted section 182. These initial locations are shown in Figure 3.3.
In the model, these calcified zones were modeled with stiff shell elements on the aortic-facing
surface of the valve. Our current disease progression model depends on two parameters. The first
is the age of onset, at which calcified zones are first added to the model. Second, we assume a
simple growth law for the nodes: the boundary is allowed to spread outward at a constant speed.
This speed, the growth rate, is the other parameter. We ran our model with onset ages from 40 to
70 years and growth rates from 0.25 mm/year to 1.0 mm/year.
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Figure 3.3. Simulated growth of calcified nodes
The percentage of the total leaflet area that is covered by calcification is plotted versus time in
Figure 3.4 given a constant growth rate of 1 mm/year. With the boundary moving at a constant
speed, the calcified area increases quadratically before saturating when the whole leaflet is
covered. For each age of onset, the valve was simulated with each rate once for every year until
the model valve was entirely calcified.
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Figure 3.4. Percent of leaflet covered by calcification versus time
A number of measures of overall valve function and progression of valvular disease have been
suggested, including peak fluid velocity, pressure drop across valve, effective orifice area, valve
resistance 5, 17, 69, energy loss 75 , rate of change in valve area11 2 , and others 1 ', 183. To track the
overall valve function over time in our simulations, we calculate the peak fluid velocity and
aortic valve opening area (AVA) at each age. These measures were chosen because they are
recognized clinically and straightforward to measure both in the clinic and simulation.
Additionally, the area is an intrinsic measure of valve function, relatively insensitive to varying
boundary conditions17. The peak velocity for each simulation is simply the maximum fluid
velocity in the simulated cardiac cycle. AVA for each simulation is the maximum value of the
area calculated throughout the cardiac cycle using the Gorlin formula . Simulation results were
compared to experimental data for a typical case of valve aging with CAS. Piper et al, 2004
gives experimentally-derived functions for AVA versus age given the calcification state of the
valve at one point in time 41. We compared our predicted AVA to the experimentally-determined
curve for a valve which is unobstructed until onset of calcification at age 50141. We also
compared our predicted peak velocities to a curve calculated from the experimental AVA by the
Gorlin formula.
Results
All simulations ran to convergence with no instabilities. Computation time was approximately 3
hours per each cardiac cycle on a workstation with four Xeon 5160 3.00 GHz processors.
In both normal aging and calcification, overall valve function, measured by fluid peak velocity
and valve orifice area, degraded over time. Results are shown graphically in Figure 3.5, where
the computed geometries are shown at mid-diastole for a range of ages. At each age, a section
view overlaid with fluid velocity vectors is shown and a view of the whole valve seen from the
aortic orifice. These plots show qualitatively the valve orifice narrowing both in normal aging
and CAS.
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Figure 3.5. Computed geometries and flow velocities at mid-systole at various ages. Assumptions
for calcification model are onset at age 50 and a growth rate of Imm/year.
Computed peak velocities and areas for are compared to experimental data in Figure 3.6 and
Figure 3.7, respectively. The theoretical curve in those figures has onset at 50 years and a range
of growth rates. The experimental data is the typical curve for a patient where calcification
appears at 50 years in a previously unobstructed valve 141. The plots are overlaid with clinically
accepted values for grading the severity of valve disease 35. In both plots, the theoretical model
tracks the experimental data best with lower growth rate in the years immediately after onset of
calcification and with higher growth rate in the years after that.
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Sensitivity of the model to the two input parameters was analyzed. The age of valve failure,
defined as the age when the area reached < 1.0cm 2 21, was recorded for all combinations of the
input parameters. Figure 3.8.A shows the age where the valve fails versus the defined age of
calcification onset, with curves for various growth rates. Figure 3.8.B shows the age at valve
failure versus growth rate, with various ages of onset.
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Figure 3.8. Sensitivity of model to input parameters: a) age where valve fails versus onset age,
with various growth rates and b) age where valve fails versus growth rate, with various ages of
onset
Discussion
We have introduced a model for the mechanical effects of aging in the AV, including normal
stiffening and thickening as well as progressive calcification. There are many approximations
made in this model. First, a number of assumptions are made to construct a model of the valve at
any point in time. These assumptions, which we have previously discussed in detail' 93, include
simplified representation of the geometry, modeling the interaction of the valve with its
environment through pressure and displacement boundary conditions, and assumptions inherent
to the material models: a discrete fiber model for the leaflet mechanics, simple Mooney-Rivlin
for the sinus wall, and Newtonian flood for the blood.
Further assumptions were made to model the changes in the valve over time. In normal aging,
the most significant source of error is our scaling of the leaflet extensibilities. Our model was
extrapolated from the known data39, which provides only the change in radial extensibility, and
does not give reference to a no-stress state. Changes to the valve other than leaflet thickening and
stiffening were not included in the model.
Calcification was modeled simply as the addition of stiff shell elements on the aortic surface.
Calcification sites were assumed to appear simultaneously at different locations in the valve,
where physiologically they arise at different times. The nodes were modeled as thin shells,
though in CAS the calcifications are known to develop significant thickness.
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Our current model assumes two input parameters, the age of calcification onset and the
calcification growth rate. Sensitivity analysis shows that the model's ability to predict overall
valve function, measured by when the model predicts valve failure will occur, is sensitive to both
parameters.
Our model provides a framework for linking overall valve function to valve mechanical
properties and geometry. This model qualitatively captures the valve narrowing and increase in
fluid velocity seen in patients. With proper choice of input parameters, the model can
approximate experimental data for disease progression. Determination of the values for those
parameters, however, will require significant experimental work. If the age of onset and growth
behavior, which likely does not follow the constant-rate model we have assumed, can be
measured, then our model can be clinically useful. A model that can take patient inputs and
predict the course of disease will be useful in deciding timing of valve replacement, and a model
that can describe the effects of pharmaceutical and surgical interventions can aid in the
development of those treatments. The model we have presented gives a theoretical basis for
understanding the link between therapy and valve function in CAS, and being able to understand
and predict the course of CAS has the potential for significant clinical impact.
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Chapter 4. A Multiscale Computational Comparison of the
Bicuspid and Tricuspid Aortic Valves in Relation to Calcific Aortic
Stenosis
Introduction
The aortic valve opens to allow flow from the left ventricle to the aorta and closes to seal against
backflow. This valve commonly has three cusps and three sinuses. In 1-2% of the population,
however, the aortic valve has two cusps65, a condition known as a bicuspid aortic valve (BAV).
Illustrations of tricuspid and bicuspid valve geometries are shown in Figure 4.1.
Serious complications develop in at least 33% of patients with BAV187 . The aortic valve is
generally susceptible to stenosis, regurgitation, and infection while the aorta is susceptible to
medial degeneration, dilation and aneurysm, and dissection65 . Of these, regurgitation is clearly a
product of the malformed geometry of the BAV. The cause of the other complications is unclear
at this time. It is conceivable that any of these diseases is more likely in patients with BAV due
simply to the geometric difference between having two cusps and sinuses instead of three. For
example, studies have examined whether creasing of the BAV leaflets gives rise to calcific aortic
stenosis (CAS) 149 and whether disrupted flow patterns in the BAV lead to aortic dilation8' 147
Alternatively, the valves may have different mechanical properties that cause a difference in
function that eventually leads the BAV to be more susceptible to disease than the TAV. Another
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possibility is that the structural differences between the TAV and BAV are not relevant to
whether the BAV is more likely to develop disease. Instead, BAV may be caused by a genetic
defect, and this same defect independently gives rise to the other diseases. Fibrillin-1 deficiency
has been notably implicated64
Much progress has been made in creating numerical simulations of heart valves over a range of
length scales. Fluid-structure interaction models for organ-scale heart valve motion have been
developed4 7, 57, 131, 193, allowing simultaneous prediction of the solid and fluid phases in the valve.
At the tissue scale, many efforts have been made recently to formulate and implement
appropriate experimentally-derived material constitutive models 160' 170, 191, 192. Cell-scale
simulations have also been created with linkage to experimental data 93 . In Chapter 2, we
described a method for simulating mechanical behavior of the aortic valve across the range of
length scales including cell, tissue, organ, and we verified the approach against experimental data
for the normal tricuspid valve193
CAS progression is a multiscale process. Organ-scale stretches are translated to the tissue and
cell scales, where dynamic deformations are imposed on the valvular interstitial cells (ICs). The
ICs are thought to mediate the disease in response to these cellular deformations"117 . Our
multiscale simulation tools allow us to examine the multiscale disease mechanisms. In this study,
we perform a multiscale analysis of the TAV and BAV in order to determine whether the
increased incidence of CAS in the BAV may be linked to a mechanical difference between the
two types of valve.
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Methods
We described a method for multiscale simulation of the tricuspid aortic valve in Chapter 2193
Here, we briefly outline the multiscale simulation methods we employ to compare the BAV and
TAV. For further details including verification of the model versus experimental data, see
Chapter 2193
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Figure 4.1. Organ-scale valve geometries, tricuspid on left and bicuspid on right. Top: full
geometry of valve. Bottom: cutaways showing tracking locations.
An overall schematic of this approach is shown in Figure 4.2. Computed local deformations of
the organ-scale model are projected as boundary conditions to the tissue-scale model. Similarly,
local deformations of the tissue-scale model are mapped as boundary conditions to the cell-scale
model.
decreasing
size
Figure 4.2. Schematic of multiscale simulation approach. Deformations are mapped from largest
scale to smallest.
First, we defined a system of reference configurations to describe the valve tissue deformations.
Our system extends that of Stella170 . In Q2o, the ventricularis and fibrosa are unattached and
stress-free. The layers are connected to form the assembled tissue Q1. In £22, the tissue is in
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position in a valve to which no pressure has been applied. When the valve is pressurized to its
resting physiological state, the tissue is in 23. We denote the time-varying state of the tissue in
the functioning valve as QO . Detailed illustration of these reference configurations can be found
in193
The organ-scale simulation considers deformations from 022 through 2 t. The organ-level
simulation was performed in LS-DYNA (LSTC, Livermore CA). This software was chosen
because its operator-splitting method for fluid-structure interaction has been demonstrated to
readily handle the motion of a solid through fluid typical of a functioning heart valve84. LS-
DYNA is an explicit solver, which means it may require excessive computation times in
modeling relatively low-speed physical systems such as the aortic valves. We addressed this
issue in our formulation of the constitutive model used to describe the cusp tissue mechanics.
To simulate the cusp mechanics, we have developed a constitutive model that describes the bulk
material behavior and is particularly computationally efficient in explicit finite element codes.
Like many tissue constitutive models 14 , 91, 173, our model treats the tissue as an isotropic solid
with embedded aligned fibers. Instead of using a continuum model, though, we took a discrete
approach. The solid mesh elements were modeled with an isotropic material. One-dimensional
cable elements were then used to connect the nodes of the solid element. LS-DYNA allows
assignment of arbitrary stress-strain curves to the cable elements, and fiber rotations follow nodal
displacements. This approach achieves enormous computational gains over a continuum
approach; for further details see Chapter 2 9
The constitutive model was constructed referring to the tissue configuration Q2. The isotropic
solid was modeled as a single-term Mooney-Rivlin with the value C1= 2.0e4 chosen to fit
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bending data for the leaflet 93' 155. The stress-strain curves in the radial and circumferential
directions measured experimentally for configuration Q2160 were discretized and applied to the
fiber elements. The aortic root was assumed to be isotropic and modeled with a single-term
Mooney-Rivlin material. A value of C1=1.0e5 was fit to experimental pressure-versus-dilation
data for the root o. Further details on the development and validation of these models are
outlined in Chapter 2193
Organ-scale geometry of the tricuspid and bicuspid valves were generated in SolidWorks
(SolidWorks, Concord, MA). These solid geometries are shown in Figure 4.1. This figure also
illustrates the locations where local deformations were monitored for translation to the tissue-
scale model. The tracking locations were chosen at two regions expected to show the highest
degree of flexure: where the leaflet attaches to the wall (labeled "attachment"), and the hinge
point where the coapted surface of the leaflet meets the free portion (labeled "coaption"). The
overall geometry of the leaflets and sinuses (heights, lengths, angles, and diameters) for
explanted valves have been measured and described in literature' 79. Finer geometric features,
including the thickness distribution at different locations on the leaflet, have also been
measured79. Based on this collection of measurements, we created the valve geometry in
SolidWorks in terms of two solid features: one loft for the sinus and one loft for the leaflet. In
this way, the complete valve geometry is described by a small number of geometric variables and
can readily be modified. Our CAD geometry represents the valve in the unstressed,
unpressurized explanted state according to observations in our lab. For simplicity and to
minimize computation time, the tricuspid valve is assumed to have 1/6 symmetry and the
bicuspid is assumed to have 1/4 symmetry. The solid domain is embedded in a fluid domain
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having the same symmetry. Entry regions were added at both ends of the valve to allow the sinus
to move radially, and fluid source domains were added at the orifices of the entry regions.
Parametric 8-node brick meshes of both the solid and fluid domains were created in TrueGrid
(XYZ Scientific Applications, Inc., Livermore CA). Cable elements representing circumferential
and radial fiber families were overlaid on the solid mesh using HyperMesh (Altair Engineering,
Troy MI), following observed fiber directions58.
Fixities and boundary conditions were applied to the mesh. Mirror conditions were applied to
fluid and solid nodes on the two symmetry planes. The unattached ends of the entry regions
were fixed while the nodes at the junction of the entry regions and the aortic root were
constrained from moving axially. Outer faces of the fluid domain were not constrained. The
same boundary conditions were applied to both the tricuspid and bicuspid models:
experimentally-derived, time-varying pressure curves for the ventricle and aorta were applied to
the appropriate fluid source domains1 79. An experimentally-derived radial displacement
condition representing ventricular contraction was applied to the base of the valve. Pressures
were slowly applied to bring the valve from its unpressurized state to its in-vivo resting position
before the transient pressures were applied.
Post-processing was performed using HyperView (Altair Engineering, Troy MI). For both
simulations, we recorded velocity profiles in the fluid phase and mechanical strains,
displacements, and flexures in the solid phase throughout the solution.
Deformations from each organ-scale model were mapped as dynamic boundary conditions to
tissue-scale models. Multilayered, undulated leaflet geometry was created in SolidWorks and
meshed in ADINA (ADINA R&D, Watertown, MA). The geometry is illustrated in Figure 4.3.
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An exponential, anisotropic constitutive model was developed and fit to experimental data170 for
each layer. The region of interest, where calcification is observed to develop1 08' 135, in the tissue-
scale simulation is the layer closest to the aortic-facing leaflet surface, the fibrosa. To examine
cellular deformations in this region, we recorded stretches in two locations of tissue-scale model,
noted in Figure 4.3. One location is on the outer edge of a curve in the fibrosa (labeled "outer"),
and one location is on the opposing inner edge (labeled "inner").
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Figure 4.3. Locations to track in tissue-scale simulation
Stretch data recorded in the tissue-scale models were mapped as boundary conditions to the cell-
scale models. The cell-scale model is comprised of a cell in matrix. Geometry, shown in the cell-
scale portion of Figure 4.1, was created and meshed in ADINA. The cell was modeled by a
single-term Mooney-Rivlin 93 and the matrix was modeled using the constitutive model
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developed for the fibrosa in the tissue-scale model1 93. Cell aspect ratio (CAR) was recorded
versus time for the tricuspid and bicuspid valve, and the results compared to each other.
Results
Multiscale simulations linking cell-, tissue-, and organ-scale models were run to convergence
with no instabilities. Computation time for the organ scale models was approximately 3 hours for
each cycle of opening and closing on a workstation with four Xeon 5160 3.00 GHz processors.
Computation time for the cell and tissue models was a few minutes per cardiac cycle.
For the organ-scale model, deformed configurations of the TAV and BAV valves are illustrated
at different times in Figure 4.4 and flow fields at mid-systole are shown in Figure 4.5. Overall
dynamics of the tricuspid and bicuspid valves are similar. Since we defined the material
properties, especially the extensibilities, to be the same in the leaflets and wall of the two valves,
the leaflet strains and wall displacements had similar magnitudes and temporal trends.
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Figure 4.4. Predicted geometries of TAV and BAV at mid-systole and mid-diastole
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Figure 4.5. Predicted flow fields in tricuspid (top) and bicuspid (bottom) valves at mid-systole
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Two main differences were observed between the tricuspid and bicuspid valves. First, the
bicuspid valve did not open fully, creating a jet in the fluid not seen in the tricuspid valve.
Comparative velocity profiles at the aorta entrance are plotted in Figure 4.6. Second, kinks
formed in the bicuspid valve leaflet when open, whereas the tricuspid valve leaflets opened in
smooth curves. This effect is reflected in Figure 4.7. In that figure, we have plotted the time-
varying leaflet flexures in each valve measured at two points: where the leaflet attaches to the
wall and where the coaption region begins. At each position, the bicuspid valve undergoes
flexures of significantly greater magnitude than the tricuspid valve.
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Figure 4.6. Fluid velocity profiles at entrance to aorta in tricuspid and bicuspid valves
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Figure 4.7. Dynamic flexures in bicuspid (left) and tricuspid (right) valves
Deformations occurring at the cell level associated with the organ-scale deformations described
above are plotted in Figure 4.8. In the region of interest (points marked in Figure 4.3) dynamic
CARs are very similar between the BAV and TAV.
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Figure 4.8. Dynamic cell aspect ratios for TAV and BAV
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Discussion
We have created multiscale simulations of the TAV and BAV, where the only difference
between the two simulations is the number of cusps. At the organ-scale, this geometric variation
causes two major differences in function. Firstly, the leaflets of the bicuspid valve do not open as
smoothly and undergo more flexure relative to the normal tricuspid valve. Secondly, the bicuspid
valve does not open as widely and the blood passing through the valve at systole forms a jet.
Both differences in organ-scale behavior agree with experimental observations 113, 148
For both the TAV and BAV, deformations were mapped to the tissue and cell length scales. At
the cell scale, we examined cellular deformations in the region associated with CAS.
Interestingly, no appreciable differences were found in cellular deformations at the CAS-relevant
regions. We observed that the wrinkled structure of the fibrosa serves to shield the cells within
from strain. Thus, while greater deformations were seen in the bicuspid valve at the organ scale,
we found that these differences did not translate down to the cell level.
Since valvular interstitial cells can only sense the cell-scale deformations, our model predicts that
these cells experience similar mechanical stimuli in the TAV and BAV regardless of organ-scale
differences. Thus, our results suggest that the observed difference in calcification between the
TAV and BAV is not due to a difference in mechanical deformation. The difference in
calcification may instead be due a genetic difference which both determines the number of
leaflets and the calcification risk. Evidence is mounting for a genetic cause of BAV43 59, and that
this genetic difference gives rise to a difference in the matrix constituents throughout the valve
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64. The fact that the BAV is more prone to a number of tissue diseases, including aortic dilation
and aortic dissection, further suggests that the BAV is accompanied by dysfunctional tissue
structure2, 113, 134. There remains the possibility that this difference in biochemical tissue
structure between the BAV and TAV causes a difference in mechanical behavior, which then
leads to deformations of the BAV that in turn lead to increased incidence of CAS. This effect
could be investigated using our model if data on the mechanical properties of BAV were
available. Currently they are not. Unless the BAV fibrosa structure is greatly different from that
of the TAV, we would still expect to observe the strain-shielding effect on the cellular
deformations in the region of interest that we found in the current study.
In this paper, we analyzed the mechanical differences between the tricuspid and bicuspid aortic
valves over a range of length scales. We showed that cellular deformations in the region
associated with CAS are not significantly different between the two valves. This result suggests
that the difference in calcification risk between the two valves is not due to differences in
deformation, and may instead be due to the genetic difference in matrix components.
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Chapter 5. Hemodynamic environments from opposing sides of
human aortic valve leaflets evoke distinct endothelial phenotypes
Introduction
Calcific aortic stenosis (CAS) is the most common heart valve disease in the western world42.
Early lesions are prevalent in adults of all age groups 10 8, with early calcific sclerosis present in
20-30% of individuals over 65 years and 48% of those over 85 years42' 132. In CAS, these lesions
form large calcific nodules which can severely impair valve function. Clinically significant
stenosis affects 2% of individuals over 65 years and 4% over 8542. The first stage of CAS, aortic
valve sclerosis, is characterized by the appearance of lesions similar in some respects to those of
atherosclerosis' 108, 138. Both the initial lesions and calcified nodules develop predominantly in the
fibrosa, the collagenous layer of the valve leaflet below the aortic-facing surface l08' 135, 179 The
initial calcific lesions are nucleated in the valvular interstitial cells (IC) 10 2, 103. CAS is likely
potentiated by the effects of biomechanical forces acting on the valvular endothelial cells (EC)
and/or the IC, but it remains unknown how each cell type is affected and whether the key
disease-inducing forces are solid deformations 49, hemodynamic shear forces 24, or a
combination of the two. Our recent efforts have used computational models to demonstrate the
uncertainty of linking cell-scale deformations to CAS processes190. In that work, we investigated
the multiscale mechanical deformations in the normal (tricuspid) aortic valve and the bicuspid
aortic valve. We showed that, while organ-scale deformations were different between the
tricuspid and bicuspid valve, differences in cell-scale deformations were small and could not
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explain the difference in calcification between the two valves. In this chapter, we use numerical
models, in combination with in vitro cellular approaches and in vivo gene expression, to generate
side-specific aortic valve hemodynamic waveforms and investigate the link between these
specific waveforms and the endothelial phenotypes they evoke.
It is well established that hemodynamic forces acting along the endothelium differ between the
two sides of the aortic valve leaflet 55' 194, leading some to hypothesize that the side-specific
nature of CAS may arise from flow-mediated differences in aortic valve endothelial cell
phenotypes. In support of this hypothesis, studies from explanted porcine aortic valves and
cultured porcine aortic valve endothelial cells have demonstrated that the two sides of the leaflet
display marked differences in expression of genes specific to vasorelaxation, inflammation, and
bone-deposition processes, including C-natriuretic peptide (CNP) and bone morphogenic protein
4 (BMP-4)25' 167. The goal of the study reported in this paper is to investigate the effect of aortic
valve side-specific hemodynamic waveforms on EC phenotype using physiologically relevant
waveforms. We hypothesize that the different pattern of shear stress on the two sides of the
aortic valve cusp generates a CAS-vulnerable EC phenotype on the distal/outflow side and a
CAS-protective EC phenotype on the proximal/inflow side. Generating a reliable experimental
measurement of the dynamic shear profiles in the valve, however, has proven difficult to-date.
Different researchers have reported a wide range of peak shear stresses, ranging from 29-1200
dynes/cm 2 55, 194. We created a computational model to calculate the transient shear stress
waveforms that act on each side of the aortic valve. We then applied the computed shear stress
waveforms from both the aorta and ventricle-facing leaflet surfaces to cultured human
endothelial cells and measured differences in endothelial genes that have previously been
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correlated with vascular inflammation and atherogenesis. Among these genes, we assessed the
expression of the endothelial transcription factor Kruppel-like factor 2 (KLF2), a gene that we
and others have shown act as an integrator of the endothelial atheroprotective phenotype
45
' 50, 74,
140. In addition, the expression of KLF2 was documented in tissue using in situ hybridization in
mouse aortic valve tissue. Our results describe a connection between the shear stress experienced
by aortic valve endothelium and endothelial gene expression and function that may play a role in
the mechanism of aortic stenosis.
Materials and Methods
Computational Model
To accurately calculate the shear waveforms applied to each side of the aortic valve leaflet, we
created a 2-dimensional fluid-structure numerical simulation of the human aortic valve. This
model is a simplified version of the 3-dimensional simulation we have described in previous
chapters1 93, but with high resolution on the fluid boundary to accurately resolve the wall shear
stress patterns. Our previous model uses the operator-split method to handle fluid-structure
interactions, where the deforming solid passes through a stationary fluid mesh. With operator-
split, accurate calculation of the momentum boundary layers requires high resolution throughout
the fluid mesh, and thus high computational cost. In order to resolve the momentum boundary
layers and accurately compute the shear stress applied to the valve surfaces, we modified the
previous model by employing the Arbitrary Lagrangian-Eulerian (ALE) method. With ALE, a
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fine fluid mesh remains attached to the solid boundaries while mesh in the bulk can be coarser.
Geometries of the solid and fluid were created in SolidWorks (SolidWorks, Concord, MA) based
on experimental measurements of overall valve geometry1 79 and of thickness at various locations
on the cusp79. The full 3-dimensional geometry is shown in Figure 5.1.A, with a cutaway
showing a plane of symmetry along the center of a leaflet. The solid and fluid geometry in that
plane are the 2-dimensional geometries for the current model. Geometry was meshed in ADINA
(ADINA R&D, Watertown, MA).
Figure 5.1. Aortic valve geometries. A) Full 3-d geometry, created in CAD software based on
experimental measurements, showing symmetry plane and B) Meshed 2-dimensional simulation
geometry. Aortic-facing and ventricular-facing surfaces are illustrated.
Both the solid and fluid phases were meshed with 3-node triangular elements. To permit large
displacements of the solid, the Arbitrary Lagrangian-Eulerian (ALE) method with remeshing of
the fluid was used. The solid phase was modeled with an exponential Mooney-Rivlin material
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model with constants fit to experimental data' 3' 14, 193 (DI=1000 Pa, D2= 30) and blood modeled
as a Newtonian fluid (j=0.003 Pa s). Spring elements with a locking stretch of L=1.25 were
added to represent the effect of the connection of tissue between the center of the leaflet and the
commissures. Simulation geometry, including the solid phase, fluid phase, and added spring
elements, is illustrated in Figure 5.1.B. The simulation was run in ADINA, subject to dynamic
pressure boundary conditions1 93. Shear profiles applied to the aorta-facing and ventricle-facing
surfaces were recorded versus time for one cardiac cycle and averaged over the locations shown
in Figure 5.1.B.
Shear Stress Application
The two computed shear waveforms were applied to cultured endothelial cells using a cone-and-
plate dynamic flow system (DFS), as previously described 45 . Briefly, the DFS rotates a modified
cone over a plate seeded with a confluent monolayer of endothelial cells. The cone is driven by
a computer-controlled stepper motor (Zeta6104, Axis New England). The design parameters
(e.g., cone angle, plate diameter, and medium viscosity) had been evaluated to ensure that the
flow is laminar, and that the shear stress is directly proportional to the angular velocity of the
cone. Precise control of the cone rotation therefore allows the device to simulate various shear
stress waveforms. For each set of experiments, two identical flow devices were used
simultaneously. One of them was programmed to simulate the aorta-facing waveform, whereas
the other was used for the ventricle-facing waveform (Figure 5.2).
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Human Endothelial Cell Culture
Human umbilical vein endothelial cells (HUVEC) were isolated and maintained as previously
described 45 . Briefly, HUVEC (passage 1) were plated on 0.1% gelatin (Difco)-coated
polystyrene circular plates (Plaskolite) at a density of 60,000 cells/cm 2 and maintained at 37 C
and 5% CO 2 in Medium-199 (BioWhittaker) supplemented with 50 gig/ml endothelial cell
growth supplement (Collaborative Research) 100 gg/ml heparin (Sigma), 100 units/ml penicillin
plus 100 gg/ml streptomycin (BioWhittaker), 2 mM L-Glutamine (Gibco), and 20% FBS
(BioWhittaker). After 24 hours, the plate was assembled in the DFS and the HUVEC
monolayers were exposed to the aortic-facing and ventricular-facing waveforms using the
medium described above with an additional 2% wt/v dextran (Invitrogen) in order to achieve a
fluid viscosity of 2.15 cP. The waveforms were applied for 24 hours, over which interval the
medium was exchanged at a rate of 0.05 ml/minute. The 24-hour time point was selected for
comparison between waveforms to allow transient changes in transcription that primarily reflect
the step-like transition from the static condition to a fluid dynamic culture condition to subside,
which has previously been used as a steady-state approximation for characterizing flow-
dependent endothelial phenotypes74
RNA Isolation and Gene Expression Measurement
Total RNA was isolated using Lysis Buffer (Applied Biosystems) and purified using the Prism
Nucleic Acid Prep-Station (Applied Biosystems) according to the manufacturer's instructions.
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RNA quantity was measured by spectrophotometic analysis at 260 nm and quality was verified
by Agilent's 2100 Bioanalyzer with RNA 6000 Nano LabChip Kit. Purified, DNase-treated
RNA (0.5 ptg) was reverse-transcribed using a MultiScribe-based 25 dtl reaction (Applied
Biosystems). The cDNA was diluted in 50 p1 DNAse-free water and subjected to a 20 •l real-
time TaqMan quantitative PCR (Applied Biosystems 7900). Expression of Kruppel-like Factor 2
(KLF2, TaqMan probe Hs00360439_gl), Nephroblastoma Overexpressed (NOV, TaqMan probe
Hs00159631_ml), Monocyte Chemoattractant Protein 1 (MCP-1/CCL2, TaqMan probe
Hs00234140_ml), and VE-Cadherin (CDH5, TaqMan probe Hs00174344_ml) were reported
relative to GAPDH (TaqMan probe Hs99999905_ml) and normalized to aorta-facing expression
levels. The data reported represents the mean of three independent experiments with the error
bars representing standard error. Differences were considered statistically significant for P <
0.01, as determined by one-way ANOVA (Primer of Statistics).
In Situ Hybridization (ISH)
14.5 day mouse embryos were fixed in 4% paraformaldehyde and embedded in paraffin. 10 gim
sections were then taken and ISH carried out using digoxigenin (DIG)-labeled mouse PECAM
and KLF2 riboprobes. A PCR amplified fragment of mouse PECAM cDNA (Primer F: 5'-
CCAACAGAGCCAGCAGTATGAGGACCAG-3' and Primer R: 5'-
CACCCCCCGAAACACAAGGAAGATAGG-3') as well as a PCR amplified fragment of
mouse KLF2 cDNA (Primer F: 5'-TACCGAAAGCACACAGGTCA-3' and Primer R: 5'-
CCTCCAAAGATCCAAAACTTTA-3') were used as templates for synthesis of the riboprobes.
In situ hybridizations were carried out as described by Brent et al. 200322
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Results
Numerical simulations of the biomechanical forces acting on the aortic valve were run to
convergence for one full cardiac cycle, yielding deformed geometries and fluid velocity profiles
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Figure 5.2.A). Bulk velocity profiles match those of our previous models and experimental
data' 79, 193, and finely resolved velocities at the fluid boundaries were used to extract time-
varying shear waveforms for each face of the valve (Figure 5.2.B).
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Figure 5.2. Results of numerical simulation. A) Deformed geometries and fluid velocity profiles
in systole and diastole and B) shears recorded for typical locations on aortic-facing and
ventricular-facing surfaces.
The ventricle-facing waveform reached higher magnitudes (40 dynes/cm 2 maximum, an average
of 4.7 dynes/cm2 over the cardiac cycle), and does not exhibit flow-reversal, while the aortic-
facing waveform contains significantly lower magnitudes (3 dynes/cm 2 maximum, an average of
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0.07 dynes/cm 2 over the cardiac cycle) with flow-reversal. The computed hemodynamic
waveforms, however, are notably different from others that have been used to investigate the
effect of shear forces on endothelial phenotype45. In the systemic vasculature, arterial shear
forces have a time-varying component, but typically remain non-zero throughout the cardiac
cycle. In contrast, the aortic valve experiences a spike in shear during systole when the valve is
open and blood is being ejected from the left ventricle and zero shear during diastole when the
valve is closed, as reflected in the simulated valve waveforms (see Figure 5.2).
Application of the simulated aortic valve waveforms to cultured HUVEC, a human endothelial
cell that has been previously shown to display significant plasticity when exposed to shear stress
in culture for 24 hours34' 45, 74, 120 resulted in the differential expression of endothelial genes that
regulate vascular homeostasis and may be important for the initiation and progression of CAS.
In particular, exposure of HUVEC to the ventricle-facing valve waveform resulted in increased
expression of the vasoprotective transcription factor KLF2 and the matricellular protein NOV, as
well as decreased expression of pro-inflammatory molecule MCP-1. There was no change in the
pan-endothelial marker VE-Cadherin in cells exposed to the ventricle-facing valve waveform
compared to the aorta-facing waveform (see Figure 5.3.A). Moreover, in order to verify KLF2
expression in vivo, in situ hybridization was performed on mouse embryos at a developmental
stage when circulation is fully established (E14.5). In these embryos, we did observe a marked in
vivo side-dependence expression of KLF2 with higher levels in the ventricle-facing endothelium
(see Figure 5.3.B), the side of the developing valve exposed to high flow. It is not known,
however, what the specific characteristics of the waveforms generated by flow in these regions
of the mouse valves are and how they compared with the human ones simulated in this study.
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Figure 5.3. A) Ventricle-facing aortic valve waveforms evoke an anti-inflammatory endothelialphenotype, as assessed by KLF2, NOV, and MCP-1 gene expression. VE-Cadherin expression, apan-endothelial marker, showed no difference in expression between the two flow patterns. Datais the average of 3 independent experiments with the error bars representing +/- the standard error.
* P < 0.01, as determined by one-way ANOVA. KLF2 = Kruppel-like Factor 2; NOV =Nephroblastoma Overexpressed; MCP-1 = Monocyte Chemoattractant Protein 1. In Situhybridization validating the side-dependent KLF2 expression B) E14.5 mouse embryo aorticvalves and C) PECAM control staining of the endothelium. Arrow heads indicate the aorta facing
surface and lack of KLF2 expression.
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Discussion
CAS represents an important pathological state of cardiac valves in which individual valvular
interstitial cells develop calcific deposits, which eventually coalesce, leading to macroscopic
calcified nodules, some lesions evolve in the context of an inflammatory focus that resembles the
lesions of atherosclerosis. However, the cellular and molecular mechanisms leading to this
pathogenesis remain unknown. In particular, the effect the hemodynamic environment has on
valvular cells, as well as the valve structure and function, has gained recent attention 67. In this
chapter, we developed a finite element fluid-structure simulation of the aortic valve motion, with
high resolution at the fluid boundary, in order to generate physiologically-relevant hemodynamic
waveforms acting along the aorta and ventricle-facing valve endothelium. The simulated
waveforms (Figure 5.2.B) were applied to cultured human endothelial cells and we documented
that the cells exposed to the ventricle-facing waveform display an anti-inflammatory phenotype,
as determined by the increased expression of KLF2 and NOV, as well as the suppression of
MCP-1, compared to cells exposed to the waveform from the aortic-facing side of the leaflet. It
is important to note that endothelial cells derived from the umbilical vein do not represent the
ideal cell type to use in the study of endothelial responses to valvular hemodynamic forces.
Nevertheless, endothelial cells derived from human cardiac valves are not routinely isolated and
grown; however, HUVEC represent a cell with proven phenotypic plasticity and in the context of
specific hemodynamic environments may recapitulate several critical aspects of the endothelial
cells lining cardiac valves. Furthermore, we have confirmed here the side-specific expression of
KLF2 in the mouse aortic valve endothelium using in situ hybridization, a result that has also
been recently reported by others"'.
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Previous studies have shown that endothelial KLF2 mutes the expression of genes associated
with vascular inflammation, thrombosis, and calcification in the context of pro-inflammatory
stimuli. These two pathophysiological processes are linked to atherogenesis, and may also be
relevant to the pathogenesis of CAS 140 . One of the factors suppressed by KLF2 is bone
morphogenic protein 4 (BMP4), a gene shown by others to display valve leaflet side-dependent
expression24 25, 167. Endothelial KLF2 is highly regulated by hemodynamic forces present in
large arteries 50' 51, 140, but in addition Statins, a widely prescribed cholesterol-lowering class of
drugs, have also been shown to increase the expression of this transcription factor in the vascular
endothelium 40, and this expression is necessary for the Statin-mediated expression of several
vasoprotective genes. Importantly, recent clinical data have suggested that Statins may exert a
protective effect against the progression of aortic valve calcification 128 , 129. Taken together, these
data suggest that KLF2 expression may be a clinically relevant for the valvular endothelial cell
phenotype and that sustained expression of KLF2, as is seen on the ventricle-facing side of the
valve leaflet, may protect against CAS initiation and progression.
This work constitutes additional evidence supporting the hypothesis that hemodynamic forces
may act as important determinants in the development of CAS. Thus, it is possible that the
difference in hemodynamic waveforms acting on the leaflets of valves are critical for the
establishment and maintenance of different endothelial phenotypes between the two sides of the
leaflet, with the ventricular-facing surface displaying an anti-inflammatory phenotype. This
difference in phenotype may subsequently drive the side-specific nature of lesion formation in
CAS. Recognizing these specific molecular determinants, in combination with improved abilities
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to model the valve mechanics, may ultimately enable further understanding of the disease and
design of therapies and prevention for CAS.
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Chapter 6. Conclusion
Thesis Accomplishments
This thesis makes two main contributions to the field of heart valve research. First, it presents a
multiscale model of human aortic heart valve mechanical behavior. This model allows, for the
first time, prediction of mechanical behavior at the cell, tissue, and organ length scale. Since
biological processes in the valve span multiple length scales in both health and disease, the
model is useful to investigate many facets of valvular function. The second major contribution of
this thesis is one such investigation. The multiscale model was employed in a three-part
investigation into the mechanisms of the disease calcific aortic stenosis. Each part of this study
provides useful insight into CAS.
Chapter 2 described the formulation of a three-dimensional, dynamic, multiscale model of aortic
valve mechanical behavior. This model is depended on a number of enabling contributions. A
system of reference configurations was introduced to allow communication between the various
length scales. Within that framework, models of the cell and tissue mechanics were created. Both
models include accurate and rigorous constitutive material models, and are fully three-
dimensional. A computationally efficient discrete-fiber material model was introduced for use in
the organ-scale model. The model described in Chapter 2 allows, for the first time, theoretical
modeling of the mechanical function in the aortic heart valve across the cell, tissue, and organ
length scales. Since biological processes in health and disease span these scales, our model has
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wide utility in further investigations of valve biology. The rest of this thesis describes one such
investigation.
Chapters 3, 4, and 5 each took a separate approach at investigating mechanisms of CAS. In
Chapter 3, the multiscale model of the aortic valve was extended to model aging in the valve.
This model linked the mechanical effects of aging at the tissue scale, both normal and due to
CAS, to changes in organ scale valve function over an individual's lifetime. As such, this model
is useful in further investigations of processes that involve valve aging. These include further
study of CAS and other degenerative diseases, development of clinical indices for valve
function, and evaluation of treatments for valve disease.
In Chapter 4, we performed a multiscale analysis of the solid deformations related to CAS in the
tricuspid and bicuspid valve. These deformations are translated from the organ scale, through the
tissue scale, to the cell scale. We showed that, while deformations were considerably different
between the two valves at the organ level, the differences were slight at the cell level. Since the
deformations important in mechanotransduction are those observed on the cell scale, this work
contributes evidence that the difference in likelihood of calcification between the tricuspid and
bicuspid valves is not to due to the difference in solid deformations.
Chapter 5 describes an experimental and theoretical inquiry into the role of fluid shear in CAS.
We first developed fluid-structure organ scale simulation of valve motion with high resolution in
the fluid. This model makes the significant contribution of accurately predicting the transient
shear waveforms in the valve, where previously there was a wide range of experimental and
theoretical error. Experimental evidence showed that the predicted shear waveforms evoked
specific EC phenotypes that correlated well with spatial arrangement of phenotypes and
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calcification in natural valves. This work contributes significant evidence that fluid shear has an
important, mediating role in the disease CAS.
Future Directions and Applications
One future direction for the work presented in this thesis is to continue developing and refining
the theoretical models. Our model spanning the cell, tissue, and organ scales can be extended
downwards to the molecular scale. Such a model would be useful in investigating the molecular
signaling cascade related to solid deformations in the valve. Alternatively, our model of the valve
could be extended to larger scales, incorporating the valve function into a model of the heart and
cardiovascular system. That model would have application in examining the effect of valvular
disease on overall cardiovascular health.
The directions that hold promise for making the most significant contributions involve coupling
the theoretical models presented in this thesis with experimental work. There are two major
directions where combined theoretical and experimental work will be useful. First, the theoretical
model enables many investigations into biological processes in the valve, either in health or
disease. Chapter 5 is the first example of this sort of effort. We have provided some evidence for
theories about CAS, but the complete mechanism of this disease and others are far from clear.
The second application of theoretical valve models is in improving clinical care. Theoretical
models provide the previously unavailable ability to describe the multiscale function of the
valve, which will allow better understanding of current surgeries, pharmaceutical treatments, and
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clinical indices for disease. The predictive power of these models will enable development of
improved methods of clinical care of patients with valvular disease.
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